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"Reza a tradição bíblica que a ausência de trabalho - a ociosidade - era a condição de 
felicidade do primeiro homem antes da sua queda. O amor à ociosidade permaneceu 
também no homem caído, mas a maldição continua a pesar sobre o homem, e não só 
porque temos de ganhar o nosso pão com o suor do rosto, mas também porque, pelas 
nossas características morais, não podemos ser ociosos e calmos. Uma voz secreta 
diz-nos que devemos sentir culpa da nossa ociosidade. Se o homem pudesse achar um 
estado em que, sendo ocioso, se sentisse útil e ciente do dever cumprido, acharia uma 
das facetas da felicidade primitiva." 
 
Lev Tolstói, Guerra e Paz, 1869 
 
"Não gostaria que alguém adoptasse o meu modo de vida por motivo nenhum; pode 
ocorrer que antes que o aprenda, eu já tenha descoberto outro para mim, e além disso 
desejo que haja no mundo tanto quanto possível pessoas diferentes. Gostaria, sim, que 
cada um se empenhasse em descobrir e seguir seu próprio caminho, em vez do 
trilhado pelo seu pai, sua mãe ou seu vizinho. Que o jovem construa, plante ou viaje, 
contanto que não seja impedido de fazer aquilo que, segundo ele, gostaria de fazer."  
 
Henry David Thoreau, Walden, 1854 
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RESUMO 
  
 O hipocampo é a estrutura cerebral mais estudada na investigação 
neurocientífica. A subdivisão CA1 do hipocampo contém a população neuronal que 
apresenta menor heterogeneidade entre neurónios, encontrando-se organizada em 
camadas bem definidas, o que torna os neurónios fáceis de identificar e de estudar 
(Szilágyi et al. 2011).  
O neurónio é a unidade sinalizadora individual do sistema nervoso central 
(SNC). Os neurónios estão inseridos numa complexa rede de circuitos neuronais que 
se encontra distribuída por todo o cérebro, comunicando entre si através de sinais 
eléctricos designados como potenciais de acção e potenciais sinápticos (Adrian, 
1957).  
A transmissão de informação entre um neurónio localizado pré-sinapticamente 
e uma célula pós-sináptica designa-se como transmissão sináptica (Breathnach, 2005). 
As sinapses químicas envolvem a libertação pré sináptica de neurotransmissores para 
a fenda sináptica (Connors & Long, 2004), activando receptores específicos 
localizados na membrana da célula pós-sináptica (Schoepp et al. 1999).  
 Os receptores NMDA (N-methyl-D-aspartate) são receptores ionotrópicos cujo 
principal agonista endógeno é o glutamato (Bakkar et al. 2011. As suas principais 
características são a dependência de voltagem, elevada permeabilidade ao cálcio e 
cinética de activação/desactivação lenta (Doherty & Sladek, 2011). Os receptores 
NMDA são moléculas heteroméricas formadas pelas subunidades GluN1, GluN2 e 
GluN3 (Groc  et al. 2009). Na região CA1 do hipocampo, são tetra heteromeros 
compostos por duas subunidades GluN1 e duas subunidades GluN2 (Bakkar et al. 
2011), podendo classificar-se como sinápticos ou extrasinápticos (Groc et al. 2009). 
A actividade dos receptores NMDA está associada, de forma paradoxal, a 
fenómenos indutores de sobrevivência neuronal e de plasticidade sináptica (Larkman 
& Jack, 1995; Lipton & Nakanishi, 1999), e a episódios neurodegenerativos 
associados a morte neuronal (Xu  et al. 2009). A ambivalência nas consequências da 
actividade dos receptores NMDA recebe o nome de “paradoxo dos receptores 
NMDA” (Hardingham & Bading, 2010), sendo atribuída à localização sináptica 
destes receptores. De facto, a actividade de receptores NMDA sinápticos aparenta 
estar associada a fenómenos de protecção neuronal, ao passo que a actividade de 
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receptores NMDA extrasinápticos conduz a fenómenos de apoptose neuronal 
(Hardingham & Bading, 2010; Stark & Bazan, 2011).  
A actividade de receptores NMDA pode ser influenciada pela acção de 
neuromoduladores do SNC. A neuromodulação consiste na habilidade neuronal para 
modificar as propriedades eléctricas dos neurónios em resposta a mudanças 
bioquímicas intracelulares resultantes de estímulos sinápticos ou hormonais, 
permitindo ao SNC adaptar a sua capacidade de controlar funções fisiológicas num 
ambiente em constante mudança (Kaczmarek & Levitan, 1987).  
A adenosina é um neuromodulador que medeia os seus efeitos biológicos 
através de quatros subtipos de receptores: receptores A1, A2A, A2B e A3 (A1Rs, A2ARs, 
A2BRs eA3Rs) (Tsutsui  et al 2004). Grande parte das acções neuromoduladoras da 
adenosina são mediadas pelos receptores A1 e A2A (Gomes et al. 2010). Os receptores 
A1 ligam-se a proteínas Gi, cuja actividade inibe a actividade da adenilato ciclase (van 
Calker et al. 1979). Por seu turno, os receptores A2A ligam-se a proteínas Gs, que 
estimulam a expressão de adenilato ciclase (Corvol et al. 2001). Enquanto os 
receptores A1 se encontram amplamente disseminado pelo cérebro (Dunwiddie & 
Masino, 2001), os receptores A2A estão distribuídos em áreas especificas como o 
estriado (Haas & Selbach, 2000), embora estejam também presentes em outras áreas 
cerebrais (Fredholm et al. 2005).    
A adenosina é uma substância neuromoduladora capaz de inibir ou de 
estimular a neurotransmissão no SNC (Fredholm & Dunwiddie, 1988). Os receptores 
A1 reduzem a libertação de neurotransmissor e inibem a transmissão sináptica. As 
acções inibitórias mais proeminentes dos receptores A1 estão identificadas em 
sistemas de transmissão glutamatérgica excitatória, através da inibição na libertação 
do neurotransmissor glutamato (Barrie & Nicholls, 1993).  
Apesar da actividade dos receptores A2 ter um impacto limitado no controlo 
da transmissão sináptica basal, eles são cruciais no controlo da plasticidade sináptica 
(Gomes et al. 2010). No hipocampo, a utilização de agonistas (Cunha et al. 1996) e 
antagonistas (Li & Henry, 1998) específicos para estes receptores provocam, 
respectivamente, aumentos e reduções na transmissão sináptica excitatória. A nível 
pré-sináptico, os receptores A2A desempenham um papel facilitatório na libertação de 
glutamato (Lopes et al. 1999). No hipocampo, os efeitos moduladores dos receptores 
A2A sobre a actividade dos receptores NMDA é menos bem conhecida. Noutras 
estruturas cerebrais há evidências de que, a nível pós-sináptico, os receptores A2A 
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modulam a actividade dos receptores NMDA (Wirkner  et al. 2004; Tebano et al. 
2005; Rebola et al. 2008). De igual forma, sabe-se que em neurónios CA1 piramidais, 
os receptores A2A de adenosina controlam de forma directa a activação de receptores 
AMPA de glutamato (Dias et al. 2002).  
Este trabalho foi desenvolvido com o objectivo de compreender se a activação 
farmacológica de receptores A2A de adenosina pode modular a actividade de 
receptores NMDA na região CA1 do hipocampo.  
Utilizando fatias de hipocampo obtidas a partir de ratos Wistar jovem-adultos, 
os dados foram adquiridos através de técnicas de electrofisiologia, nomeadamente, 
procedimentos de patch-clamp utilizando a configuração whole-cell. Primeiramente, 
foi necessário garantir que as correntes evocadas refletiam exclusivamente actividade 
de receptores NMDA. Assim sendo, foi utilizado CNQX (10µM), um antagonista 
competitivo selectivo para receptores de glutamato AMPA e kainato. Os resultados 
não demonstram alterações significativas nas correntes (99%±2.9% n=3, p>0.05), o 
que permite concluir que as correntes registadas estavam apenas a ser evocadas pela 
actividade dos receptores NMDA.  De igual forma, para garantir que este efeito está 
dependente da activação de receptores NMDA, foi utilizado um antagonista 
especifico destes receptores. A aplicação de DL-APV (50µM) provocou um 
decréscimo muito significativo nas correntes registadas (76%±4.9% n=3, p<0.005). 
De seguida, com o objectivo de tentar encontrar um efeito modulador dos 
receptores A2A sobre a actividade dos receptores NMDA, começou-se por avaliar os 
efeitos do CGS 21680, um agonista selectivo dos receptores A2A, sobre a actividade 
dos receptores NMDA. A adição de CGS 21680 (30nM) provocou um aumento 
significativo nas correntes mediadas pela actividade dos receptores NMDA 
(23%±4,7% n=6, p<0.005). Estes dados apontam para um efeito modulador dos 
receptores A2A que potencia a actividade dos receptores NMDA em células CA1 do 
hipocampo.  
Para assegurar que este efeito reflecte um efeito modulador dos receptores 
A2A, foi adicionado o agonista CGS 21680 na presença prévia do antagonista 
selectivo dos receptores A2A, o SCH 58261. A adição de SCH 58261 (100nM) não 
causou diferenças significativas na amplitude das correntes (3%±14,5% n=3, p>0.05), 
o que significa que os receptores A2A endógenos não contribuem para o efeito 
anteriormente registado. A adição subsequente do agonista CGS 21680 (30nM), após 
a adição prévia do antagonista durante 10 minutos, não provocou alterações 
Modulation of NMDA receptor activity through adenosine A2A receptors in the hippocampus 
	  V	  
significativas na amplitude das correntes registadas (2%±9,0% n=5, p>0.05). O facto 
do efeito potenciador do agonista ser prevenido pela presença do antagonista dos 
receptores A2A, permite concluir que este efeito modulador é mediado por receptores 
A2A.  
Estes resultados sugerem que os receptores A2A modulam a actividade dos 
receptores NMDA, resultando numa potenciação das correntes pós-sinápticas 
mediadas pelos receptores NMDA. Estes resultados reflectem um efeito ainda não 
descrito das capacidades neuromoduladoras dos receptores A2A.  
Futuramente, seria importante discriminar se as correntes mediadas reflectem 
a actividade de receptores NMDA localizados sinapticamente ou extrasinapticamente, 
uma vez que a actividade de receptores NMDA localizados em diferentes áreas 
sinápticas tem implicações diferentes para a saúde neuronal. A memantina, um 
fármaco que bloqueia preferencialmente a actividade de receptores NMDA 
extrasinápticos, poder-se-á revelar uma ferramenta útil para uma investigação futura 
sobre o tema. 
 
 
Palavras-chave: Adenosina, Hipocampo, Neuromodulação, Receptores NMDA,  
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ABSTRACT 
 
Hippocampal excitatory synaptic plasticity is often considered the synaptic 
basis for memory formation. NMDAR activity is deeply involved in long-lasting 
changes in synaptic plasticity. Adenosine modulatory actions upon excitatory 
glutamatergic transmission are well described. However, the modulatory actions of 
adenosine A2ARs upon NMDARs activity in CA1 pyramidal cells have never been 
reported. Thus, the effect of A2AR activation on NMDARs-mediated postsynaptic 
currents (PSCs) was examined in CA1 pyramidal neurons of young (3-10 weeks) rat 
hippocampal slices, by using the whole-cell patch-clamp technique (Vh = -60mV). 
NMDARs-mediated currents were evoked through pressure application of NMDA 
(150µM) (selective NMDAR agonist) directly onto the cell soma. Bath application of 
A2AR agonist CGS 21680 (30nM) induced significant increases on NMDA-evoked 
currents (23%±4,7% n=6, p<0.005). To further address if this effect was caused by an 
A2AR-mediated modulation of NMDA-evoked PSCs, CGS 21680 (30nM) was 
superfused in the presence of SCH 58261 (100nM), a selective A2AR antagonist, 
which was added to the perfusion 10 minutes before the agonist. NMDA-evoked 
PSCs were not significantly altered by the presence of CGS 21680 (30nM) when 
A2ARs were previously blocked by SCH 58261 (100nM) (2%±9,0% n=5, p>0.05). To 
assure that the measured currents were elicited by NMDARs activity, CNQX (10µM) 
was used to block the activity of AMPA/kainate receptors. The results show no 
significant changes in NMDA-evoked PSCs in the presence of CNQX (99%±2.9% 
n=3, p>0.05), suggesting that these currents were mediated by NMDARs. Finally, the 
use of DL-APV (50µM) - selective NMDARs antagonist - served to further assure 
that NMDARs mediated the observed currents. In the presence of DL-APV, NMDA-
evoked postsynaptic currents significantly decreased (76%±4.9% n=3, p<0.005). 
Together these results allow to conclude that A2ARs exert a modulatory effect over 
NMDARs activity at the CA1 neurons of the hippocampus, resulting in potentiation 
of NMDA-evoked PSCs.  
 
Key Words: Adenosine, Hippocampus, NMDA receptor, Neuromodulation 
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AIMS 
1 
 
The present work was designed with the main objective of identifying a 
possible modulatory action of adenosine A2A receptor upon NMDA receptor activity 
in CA1 pyramidal cells. The inhibitory modulatory role of adenosine A1 receptors has 
already been well described and studied. However, the adenosinergic excitatory 
actions are yet to be fully understood. NMDA receptors located at the CA1 
hippocampal area are key components in several forms of synaptic plasticity and are 
involved in memory consolidation and spatial learning. Comprehending how 
adenosine A2A receptors modulate the activity of NMDA receptors in CA1 pyramidal 
cells can contribute to understand how adenosine modulates synaptic plasticity and 
memory.   
    
STATE OF THE ART 
2 
2.1 - Hippocampus – structure, populations and neuronal circuitry 
 
The hippocampus is, nowadays, the most widely studied brain structure in the 
nervous system. The interest in its study started more than a century ago sparked by 
the discovery of a prominent relationship between declarative memory and structures 
in the human medial temporal lobe, specifically the hipocampal formation (van Strien, 
2009). Scoville and Milner’s were the first investigators to address memory loss in 
humans following removal of the hippocampal region, showing in first hand that 
hippocampal structures are dedicated to memory functions, independent of other 
cognitive abilities. Besides that, even within memory, the role of the hippocampus is 
selective, both concerning time window and particular domain of memory processing 
(Eichenbaum, 2000). The ability to repeat or recognize items just brought into 
consciousness, in other words the immediate memory, is intact in patients with 
damaged hippocampal regions (Squirel et al. 1993; Corkin, 1984). Also, general 
world knowledge and ancient childhood memories doesn’t seem to be impaired. 
These early findings suggested that the hippocampal regions play critical roles 
between the initial formation of memories and their final repository in the brain 
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(Eichenbaum, 2000). Specifically, the hippocampus plays an unavoidable role in the 
expression of autobiographical episodic and spatial memories (Nadel & Moscovitch, 
1997).  
The human ability to learn, store and recover information about daily unique 
and personal events is possible due to episodic memory. Generally, these memories 
include information about the location and time of a specific event, as well as very 
detailed characterization of the event itself (Dickerson & Eichenbaum, 2010). The 
hippocampus is widely evolved in episodic memory in both humans and animals, 
playing a crucial role in the functions of this particular type of memory (Deshmukh & 
Knierim, 2011). A vast and complex network of brain areas supports episodic 
memory, including widespread neocortical association areas and components of the 
medial temporal lobe, in which parahippocampal cortical areas and the hippocampus 
are included. The general organization of this neurocircuitry system is that virtually 
all neocortical association areas send projections that converge onto the 
parahippocampal areas surrounding the hippocampus. In turn, these parahippocampal 
areas send projections to all the subdivisions of the hippocampus (Dickerson & 
Eichenbaum, 2010), through a serial and unidirectional circuit that internally connects 
the hippocampal subdivisions. This circuit starts in the dentate gyrus and passes, 
subsequently and continuously, across CA1, CA3 and subiculum neuronal 
populations.  
The most important component in the hippocampal circuitry consists in the 
trisynaptic loop, comprising the dentate gyrus, CA3 and CA1 neuron populations. The 
inflow of impulses that arrives from the entorhinal cortex and parahippocampal 
regions is propagated by excitatory synaptic transmissions that pass through the 
dentate gyrus and subsequently CA3 and CA1 regions. This information is then sent 
back to the entorhinal cortex areas, hence the trisynaptic loop (Wojtowicz, 2011). In 
the hippocampus the circuitry system is extremely important. Therefore, knowledge 
about hippocampal function is based upon neuronal interaction within this circuitry 
(Wojtowicz, 2011). Both lateral and medial areas of the entorhinal cortex separately 
send projections and information to all four hippocampal sub regions (Dickerson & 
Eichenbaum, 2010).  
The various functions of the components in the trisynaptic loop are studied in 
the standard hippocampal slice preparation, which allows the possibility to work with 
really thin slices of tissue where all three hippocampal regions and most of their 
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synaptic interconnections are visible, as it is possible to observe in figure 2.1.1  
(Andersen et al. 1971). The CA1 subdivision of the hippocampus contains the most 
studied neuronal population. This population shows less heterogeneity and the 
pyramidal neuronal cells are organized in well-defined layers that are easy to identify 
and study (Szilágyi et al. 2011).  
 
 
 
 
 
 
 
 
Figure 2.1.1 – Horizontal sectioning of the rat hippocampal formation. A. Nissl-stained section. B. 
Line drawing showing the various regions, layers, and fiber pathways. C. Timm’s sulfide silver-stained 
section. CA1 - CA1 field of the hippocampus; CA2 - CA2 field of the hippocampus; CA3 - CA3 field 
of the hippocampus; DG - dentate gyrus; EC - entorhinal cortex. Adapted from Andersen et al. (2007). 
 
2.2 - Synaptic transmission   
 
     Modern neuroscience, as we know it, was born more than a century ago when 
Santiago Ramón y Cajal found the first scientific results that supported the neuron 
doctrine. This doctrine consists in the idea that neurons work as the signalization 
functional unites in the nervous system, communicating with each other’s in a precise 
and specific way (Albright et al. 2001). The acceptance of this doctrine represented a 
radical and definitive paradigm shift to a more emphatic cellular perspective of the 
brain. Ramón y Cajal pertinent observations led to the development of the principle of 
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dynamic polarization. According to this principle, electric signalization between 
neurons is unidirectional; in other words, the signals propagate from the receiving 
pole of the neurons – the dendrites – to the presynaptic axon terminal (Albright et al. 
2001). This way, the afferent and efferent elements are associated in the grey matter 
by unidirectional contact between the neurons (Breathnach, 2005). A few years later, 
Sherrington found that not all synaptic actions were excitatory and that some of them 
can be inhibitory (Sherrington, 1932 in Albright et al. 2000). Sherington and Eccles 
discoveries implied that each neuron solves the competition between excitation and 
inhibition using, at is initial segment, a winner-takes-all strategy. As a result, an 
elementary aspect of the integrative action of the brain could now be studied at the 
level of individual cells. One could determine how the summation of inhibition or 
excitation leads to an integrated, all-or-none output at the initial segment. Although 
the initial studies were developed in motor neurons, soon it was discovered that this 
results had a predictive value in all brain neurons (Albright et al. 2001).  
The initial task in understanding the integrative functions of the brain 
consisted in twigging signal integration in individual cells. Edgar Adrian and John 
Langley, two contemporaries of Sherrington, developed methods of single-unit 
analysis within the central nervous system. With these methods, it was possible to 
study signalling in individual cell at any part of the nervous system. In the progression 
of his work, Adrian discovered that virtually all neurons use the same conserved 
mechanism for signalling within the cell (Albright et al. 2001). Therefore, the precise 
and effective communication between neurons is possible due to the transmission of 
information through the generation and propagation of an electric signal, 
acknowledged as the action potential (Adrian, 1957). In all cases, the action potential 
can be defined as a large, all-or-none, regenerative electric event that propagates, 
inexorably, from the initial segment of the axon to the presynaptic terminal (Albright 
et al. 2001). They are mediated by voltage-activated Na2+ channels, which are 
initiated following depolarization of the membrane potential to a threshold level 
(Stuart et al. 1997). As all other cells, neurons have differences in potentials across 
the cell membrane, the inside being more negatively charged than the extracellular 
side. This different in potential is known as membrane resting potential.  
Given the great number of existing neurons in the nervous system, it is vital 
the presence of appropriate and efficient communication mechanisms between 
neurons. In 1897, Sherington introduced the term synapse to describe the 
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unidirectional contacts between neurons (Breathnach, 2005). Synapses can be 
grouped in two main clusters: electric and chemical synapses. John Langley, a 
Sherrington contemporary, postulated the first scientific evidence that the majority of 
the synapses are of chemical nature (Albright et al. 2001). In fact, the main 
mechanism of synaptic transmission found between neurons comprises the 
neurotransmitter releasing chemical synapse. However, a more simpler and fast 
mechanism of signalization can be achieved through electric synapses. The main 
components of these synapses are gap junctions, which allow the ionic current to flow 
directly between neurons (Connors & Long, 2004). A big majority of electric 
synapses are appositions of neuronal membranes entitled gap junctions. These electric 
synapses, also known as electrotonic synapses, allow the communicating between 
neuronal cells with completely different functional properties than the ones used by 
chemical synapses (Bennett, 1972). In electric synapses, the transmission of 
information depends on current flow through the gab junctions that connect the 
cytoplasm of pre and postsynaptic cells. In the other hand, chemical synapses are 
separated by an extracellular space, named synaptic cleft. The communication 
between neurons becomes possible due to the release and action of chemical agents 
known as neurotransmitters. As a result of neurotransmitters release into the synaptic 
cleft mediated by presynaptic cells, specific receptors located at the postsynaptic cell 
are activated. Figure 2.2.2 displays an example of chemical synaptic transmission 
involving glutamate and AMPA receptors.   
Figure 2.2.2 – Chemical synaptic transmission. These steps can happen during chemical 
neurotransmission at the neuromuscular junction as well as in central synapses in both vertebrates and 
invertebrates. This example applies to fast synaptic glutamatergic transmission, but also to others 
involving different neurotransmitters and corresponding postsynaptic ionotropic receptors. Adapted 
from Lisman et al. 2007. 
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 The receptors located in the postsynaptic cell can belong to one of two 
receptor classes: ionotropic receptors and metabotropic receptors. Eccles and McGeer 
described in 1997, for the first time, the two main and different forms of 
neurotransmission. In the ionotropic transmission, the synaptic receptor located in the 
postsynaptic cell is an ionic channel, in which the activity is not mediated by voltage 
(as in the sodium and calcium channels), but instead by a chemical ligand, the 
neurotransmitter (Albright et al. 2000). On the other hand, the metabotropic actions of 
neurotransmitters mediate the production of second messengers that consequently 
produce metabolic alterations in the postsynaptic cell (Schoepp et al. 1999).  
Depending on the type of neurotransmitter that is mainly produced in the 
presynaptic cell and the type of receptor mainly expressed in the postsyanptic cell, 
synapses can be characterized as excitatory or inhibitory. Glutamate is the major 
excitatory neurotransmitter in the mammalian central nervous system and mediates its 
actions via activation of both ionotropic and metabotropic receptors families 
(Arundine & Tymianski, 2003). There are three different types of ionotropic 
glutamate receptors, which are named after the agonists that were originally identified 
as the substances that selectively activate them: N-methyl-D-aspartate (NMDA) 
receptors, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) and 2-
carboxy-3-carboxymethyl-4-isopropenylpyrrolidine (kainato) receptors. Concerning 
metabotropic glutamate receptors, there are eight different receptor subtypes 
identified (Kew and Kemp, 2005).    
 
2.3 - NMDA receptors 
2.3.1 - NMDA receptor characterization  
 
Understanding the functional mechanisms and the expression of NMDA 
receptors has captured a lot of attention in the last decades. The intense study and 
debate about NMDA receptors has provided a great deal of knowledge about its 
synthesis and cellular trafficking. NMDA receptor molecular and biological 
proprieties, as well as the changes in their expression during synaptic transmission, 
evolved to two vastly studied subjects mainly due to the discovery that NMDA 
receptors are key components in the induction of several forms of synaptic plasticity 
(Groc et al. 2009). Likewise, long lasting changes in synaptic efficiency caused by 
NMDA receptor activity, as well as the observation that their activity can be 
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associated to damage caused by ischemia (Rothman & Olney, 1995) and to epilepsy 
(Rogawski, 1993), were two other important factors that led to the increased interest 
in studying NMDA receptor activity (Dilmore & Johnson, 1998). NMDA receptors 
exhibit one unique property that allows them to work as a coincident detector for 
correlated activity. This integrated activity appears to be required for the refinement 
of synaptic connections throughout brain development, and for activity-dependent 
potentiation or depression of synaptic inputs (Zarain-Hezerberg et al. 2005).    
NMDA (N-methyl-D-aspartate) receptors are inotropic glutamate receptors 
(Bakkar et al. 2011). When compared with other glutamate receptors, their main 
characteristics are voltage-dependent activity, high calcium permeability and slow 
activation-deactivation kinetics (Doherty & Sladek, 2011). NMDA receptors can be 
found in the synapse, in extrasynaptic locations and presynaptically (Groc et al. 
2009). In immature hippocampal neurons, extrasynaptic NMDA receptors represent 
three-quarters of all the receptors contained in these cells. Although there is an 
increase in the amount of synaptic NMDA receptors during brain development, a 
substantial amount of NMDA receptors preserve their extrasynaptic localization 
throughout the adult life (Hardingham & Bading, 2010). In the synapse, NMDA 
receptors can be found in the postsynaptic density, where they are structurally 
organized and spatially restricted in a large signalling macromolecular complex of 
synaptic scaffolding and adaptor proteins, such as the PSD-95 (postsynaptic density 
protein 95) family of proteins, or MAGUKS (membrane-associated guanylate 
kinases). Besides regulating synaptic targeting of glutamate receptors and plasticity in 
excitatory synapses, these proteins are responsible to physically connect NMDA 
receptors to kinases, phosphatases and other downstream signalling proteins, as well 
as to metabotropic glutamate receptors (mGluRs) (Lau & Zukin, 2007).  
 
2.3.2 - NMDA receptor structure  
 
NMDA receptors are heteromeric molecules formed by three subunits, namely 
subunits GluN1, GluN2 and GluN3. Each one of these subunits contains several 
variants: single GluN1 subunits with eight splice variants, that are formed through 
different combinations in the GRIN1 gene, four GluN2 subunits and two GluN3 
subunits (Groc et al. 2009). Molecular diversity in NMDA receptor occurs due to 
alternate RNA splicing in GluN1 subunit (Lau & Zukin, 2007). Alternative splicing of 
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the same gene creates distinct isoforms responsible for NMDA receptor composition 
variation (for review see Doherty & Sladek, 2011; Zarain-Herzberg et al. 2005). 
Unlike GluN1 subunit that is constitutively expressed in NMDA receptor, GluN2 
subunit expression is largely regulated during brain development (Tabish & Ticku, 
2003). Through molecular screenings of NMDA receptor subunit composition, four 
GluN2 subunits, each encoded by a different gene, have been identified and described 
(Ishii et al. 1992). Besides these four GluN2 subunit-expressing genes, in mammals 
there is a fifth gene that encodes the GluN1 subunit, primarily identified by Moriyoshi 
in 1991 (Cox et al. 2005). A sixth unique GluN3 subunit receptor has been also 
identified and derives from a different and independent gene. The physiological 
signature of the receptor is determined by the co-association between a GluN1 subunit 
and a GluN2 (A, B, C or D), or between a GluN1 subunit and a GluN3A. It is not 
clearly understood how this co-assembles between subunits works, but it is believed 
that it reflects the genetic expression of the encoding genes in specific brain regions 
(for review see Goebel & Poosch, 1999).  
In CA1 hippocampal region, NMDA receptors are tetraheteromers, typically 
composed of two mandatory glycine-binding GluN1 subunits and two modulatory 
glutamate-biding GluN2 subunits (Doherty & Sladek, 2011). While GluN1 subunit is 
essential to the formation of a functional NMDA receptor, different combinations 
between GluN2 and GluN3 subunit types determines biophysical and 
pharmacological properties of NMDA channels (Takahashi, 2005). Therefore, GluN2 
and GluN3 subunits award distinct properties to each receptor, such as sensitivity to 
glutamate, peak open probability and response kinetics (Zarain-Herzberg et al. 2005). 
NMDA receptor subunit composition can affect the development, maintenance and 
stability of synapses through various potential mechanisms (Tovar & Westbrook, 
1999). As shown in figure 2.3.2.1 displayed below, in the synapse, NMDA receptors 
are connected to a large multi-protein complex through GluN1 and GluN2 
cytoplasmic C-terminal (Collins et al. 2006). This complex facilitates NMDA 
receptor localization in specific areas, simplifying receptor connexions to a variety of 
signalling molecules that mediate many of the effects induced by NMDA receptor 
activity (Hardingham, 2009).  
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Figure 2.3.2.1 – NMDAR macromolecular signalling complex at excitatory synapses. Synaptic 
NMDARs are localized in the postsynaptic density PSD (grey area), where they are structurally 
organized and spatially restricted in a large macromolecular signalling complex comprising scaffolding 
and adaptor proteins. These proteins physically link the receptors to signalling proteins and to group I 
mGluRs, which localize to the perisynaptic region. At mature synapses NMDARs are predominantly 
composed of GluN1/GluN2A or GluN1/GluN2A/GluN2B assemblies. The scaffolding proteins link 
NMDARs directly or indirectly to a number of signalling proteins, such as protein kinase A (PKA) and 
PKC, which are thought to be important in the regulation of NMDAR number and function at synaptic 
sites (upstream/downstream signalling molecules). Adapted from Lau & Zukin, 2007.  
 
2.3.3 - NMDA receptor activity 
 
The primary function of ionotropic glutamate receptors is to respond to 
presynaptically released transmitter by generating depolarization and excitatory 
postsynaptic potentials (MacDonald et al. 2007). In order to be active, NMDA 
receptors need to undergo membrane depolarization and the ligand binding needs to 
be present (Doherty & Sladek, 2011). As a result of their activity, rapid and high-
resolution excitatory signals are transmitted from the presynaptic neuron to the 
postsynaptic one. Temporal and spatial summation of excitatory postsynaptic 
potentials in a single postsynaptic neuron provides convergence and integration of a 
large diversity of excitatory inputs from many presynaptic neurons (MacDonald et al 
2007). NMDA receptor activity is essential for the regulation of almost all excitatory 
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activity in the brain (Doherty & Sladek, 2011). Almost every single excitatory 
glutamatergic synapse contains NMDA and AMPA receptors. However, excitatory 
postsynaptic potentials are almost entirely generated by the current flow across 
AMPA receptors, due to the NMDA receptor voltage dependence (MacDonald et al. 
2007). In fact, the present of extracellular Mg2+ leads to a fast blockage of NMDA 
receptor channel, as it is represented in figure 2.3.3.1 displayed below. 
 
Figure 2.3.3.1 – NMDA receptor at basal condition. In basal activity conditions excitatory 
postsynaptic potentials are almost entirely generated by AMPA receptors due to NMDA receptor 
voltage dependence (MacDonald et al. 2007). 
 
NMDA receptors only start contributing to the formation of excitatory 
postsynaptic potentials when occurs enough postsynaptic membrane depolarization. 
As it can be seen in figure 2.3.3.2, the summation of temporal and spatial excitatory 
postsynaptic potentials results in the ceasing of the extracellular Mg2+ blockage effect 
and in depolarization of the membrane (McBain & Mayer, 1994).	  	  
	  
 
Figure 2.3.3.2 – NMDA receptor after depolarization of the membrane. After the summation of 
temporal and spatial excitatory postsynaptic potentials the membrane is depolarized and the Mg2+ 
blockage ceases (McBain & Mayer, 1994; McDonald et al. 2007) 	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NMDA receptors are essential to LTP (long term potentiation), an activity 
dependent increase in synaptic efficiency (Larkman & Jack, 1995) mainly expressed 
in the hippocampus, which can underlay memory and spatial learning processes 
(Moriyoshi et al., 1991). This phenomenon was initially described in the seventies, 
when it was postulated that an evoked response in the dentate area by single test 
shocks to the afferent perforant pathway, often remained potentiated for a 
considerable time, even after relatively short periods of stimulation (Bliss & Lomo, 
1973). The activity of NMDA receptors results in a significant Ca2+ influx increase. 
As a consequence, NMDA receptor activity is associated with a large variety of 
intracellular signalling pathways that are dependent on Ca2+ influx variations   
(MacDonald et al. 2007).  For instance, the role of NMDA receptor in LTP triggering 
is largely associated to an increase in Ca2+ ion concentration inside the cell. This 
increase occurs when the postsynaptic cell is depolarized due to a large release of 
glutamate in the synaptic cleft. This way, the extracellular Mg2+ dissociates from the 
coupling location in the receptor, allowing Ca2+, as well as Na+ ions, to enter the 
dendritic spine. The consequent increase in Ca2+ ion concentration inside the cell is 
the critical element to LTP triggering (Malenka & Nicoll, 1999), as it is displayed in 
figure 2.3.3.3.  
  
Figure 2.3.3.3 – NMDA receptor at basal condition and after depolarization of the membrane. 
NMDA receptor activity results in a significant Ca2+ influx increase associated with a large variety of 
intracellular signalling pathways dependent on Ca2+ influx variations (Malenka & Nicoll, 1999). 
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Since their discovery in the seventies and the successful cloning of the 
receptor accomplished by Moriyoshi in 1991, NMDA receptors gain a role as one of 
the principal study objects in the attempt to discover the neurobiological mechanisms 
underlying memory and learning processes. Their study is particularly useful due to 
four unique NMDA receptor features: the extracellular Mg2+ voltage dependent 
blockage, their permeability to the passage of Ca2+, their slow kinetics and the 
presence of glycine as a co-agonist that offers another regulatory component that 
helps in the precise manipulation of these receptors (Ha et al. 2006).  
 
2.3.4 - NMDA receptor paradox    
 
   The variations in Ca2+ concentration inside the postsynaptic cell are the main 
cause underlying the “NMDA receptor paradox” (Hardingham & Bading, 2010). 
NMDA receptors are the main responsible agents for the excessive and neurotoxic 
increase of Ca2+ inside the neuronal cell. When the postsynaptic cell is exposed to 
high levels of glutamate, it can lead to an over activation of NMDA receptors and 
consequently to a significant increase in Ca2+ influx inside the postsynaptic neuron. 
Both these process can lead to cellular signalling disruption contributing to neuronal 
cell death (Xu et al. 2009). In fact, Ca2+ entrance through NMDA receptors is a 
particular efficient way of causing neuronal cell death, when compared to its entrance 
through other ionic channels (Hardingham & Bading, 2010). Glutamate excitotoxicity 
is identified as a key component in many neurodegenerative and neurologic diseases 
(Xu et al. 2009). In chronic neurodegenerative diseases, where the insult is mild, 
excessive NMDA receptor activity leads to neuronal apoptosis. On the other hand, in 
cases as stroke that can lead to ischemia, the insult is fulminant and the excessive 
activity of NMDA receptors can lead to cellular necrosis  (Lipton & Nakanishi, 1999).  
However, NMDA receptors are also linked to neuronal survival molecular 
pathways and to synaptic plasticity processes (Xu et al. 2009). They play key roles in 
controlling the morphological and functional plasticity of synapses and contribute to 
the cellular mechanisms of memory and learning. In pathologies as Alzheimer’s 
disease, synaptic plasticity is severely impaired (Schimtt, 2005). Besides allowing a 
direct signalization between neurons, NMDA receptors are also important for the 
correct neuronal development and or the establishing of synaptic contacts 
(MacDonald et al. 2007). Supressing NMDA activity in in vivo models significantly 
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increase cellular apoptosis mechanisms and traumatic lesions in developing neurons 
(Hardingham & Bading, 2010).  
During several years, the amount of Ca2+ that enters in the postsynaptic neuron 
through NMDA receptors was considered as the main and only accountable cause 
related with the different NMDA activity consequences (Lipton & Nakanishi, 1999). 
Therefore, moderated levels of NMDA activity were considered healthy for the 
neurons, while NMDA receptors over activation could lead to an overcharge of 
intracellular Ca2+ harmful to neuron health. According to this model, neuron 
responses to NMDA receptor activity can be described as a bell-shaped curve, where 
both a high and a low amount of receptor activity can be harmful for neuronal cell 
health (Hardingham & Bading, 2010).  
Due to more recent discoveries, this later model of cellular behaviour 
responses to the changes in NMDA receptor activity has been adjusted. According to 
the new perspective of this paradox, synaptic NMDA receptor location is the main 
responsible cause for the different cellular consequences following NMDA receptor 
activity (Hardingham & Bading, 2010). Recent investigations have described several 
examples of opposing effects in neuronal signalling pathways and cellular survival 
concerning synaptic and extrasynaptic NMDA receptors activity (Stark & Bazan, 
2011). In fact, the duality in NMDA receptor mediated processes varies accordingly 
to their synaptic or extrasynaptic localization. Synaptic NMDA receptors are related 
with the induction of signalling survival processes, while extrasynaptic NMDA 
receptors are associated with Ca2+ disruption and neuronal cell death (Stark & Bazan, 
2011). Therefore, cellular consequences of NMDA receptor activity are directly 
associated to the receptor localization and not only with the amount of stimulation and 
Ca2+ entrance as previously mentioned (Hardingham et al. 2002). These data can be 
better described through an “x” shaped graph (see figure 2.3.4.1 below). The 
ascendant curve of the “x” represents the upsurge in neuroprotection associated with 
synaptic NMDA receptor activity increase. This ascendant curve is superposed to a 
descendent one, that illustrates the progressive decrease in neuroprotection related 
with the increase in extrasynaptic NMDA receptor activity (Hardingham & Bading, 
2010). Accordingly to this perspective, it is not the Ca2+ overcharge per se the sole 
determinant of neurotoxicity but rather the Ca2+ influx through NMDA receptors 
localized outside the synapse that are responsible for the prejudicial cellular 
consequences. The influx of Ca2+ through synaptic NMDA receptors is well tolerated 
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by the neuronal hippocampal cells. Furthermore, it represents the required mechanism 
for the activation of genomic processes that can give rise to neuronal cells that are 
more resistant to apoptosis and oxidative processes (Hardingham et al. 2002).  
 
Figure 2.3.4.1 – Synaptic vs. Extrasynaptic NMDA receptor activity.  The schematic illustrates the 
opposing effects of increasing synaptic and extrasynaptic N-methyl-D-aspartate receptor (NMDAR) 
activity on neuronal survival and resistance to trauma. Hypoactivity of synaptic NMDARs is harmful 
to neurons. Enhancing synaptic NMDAR activity triggers multiple neuroprotective pathways and this 
promotes neuronal survival. Low levels of activation of extrasynaptic NMDARs have no effects on 
neuronal survival but increasing the level of extrasynaptic NMDAR activity activates cell death 
pathways and exacerbates certain neurodegenerative processes, thus reducing neuronal survival 
(adapted from Hardingham & Bading, 2010). 
 
Besides spatial receptor location and Ca2+ influx intensity and duration, there 
is a third factor that can influence the consequences of NMDA receptor activity. 
Subunit receptor composition may play an important role in neurotoxicity or neuronal 
survival processes (Hardingham, 2009). Excitotoxicity mediated by NMDA receptor 
activity may be triggered due to GluN2B composing subunits (Stanika et al. 2008). 
There is an ostensive correlation between the presence of GluN2B subunits in NMDA 
receptor composition, high cytosolic Ca2+ levels and susceptibility to neurotoxicity 
(Cheng et al. 1999).  
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2.4 - Synaptic vs. Extrasynaptic NMDA receptor signalling 
2.4.1 - Synaptic NMDAR-dependent neuroprotection  
 
An episode of synaptic NMDA receptor activity can induce neuroprotection 
for a long time, even after the receptor activity as ceased (Papadia et al. 2005). 
Although the processes and mechanisms through which nuclear calcium-regulated 
genomic events increase neuronal survival activity are not fully understood (Dick & 
Bading, 2010), recently some light has been shed over the subject. Figure 2.4.1.1 
presented below displays some of the neuroprotective pathways that are activated 
through synaptic NMDA receptor activity.  
Figure 2.4.1.1 – Neuroprotective pathways activated by synaptic NMDA receptor activity. 
Adapted from Hardingham & Bading, 2010.  
 
Calcium influx into hippocampal neurons through synaptic NMDA receptors 
triggers the release of Ca2+ ions from intracellular calcium stores. Eventually, these 
Ca2+ ions are transduced to the cellular soma invading the nucleus (Hardingham et al. 
2001). The spread of activity-induced calcium signals ending in the cell nucleus 
represents a main route for the communication between the synapse and the cell 
nucleus (Zhang et al. 2009). Nuclear Ca2+ is known to be one of the more potent 
inducers of neuronal gene expression (Hardingham & Bading, 2010). Changes in the 
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expression of pro-survival genes result in mitochondrial health improvement, the 
increase of antioxidant defences and the suppression of caspases.  
Nuclear calcium-regulated genes are accountable for a neuroprotective shield 
that neurons build when the synapses are activated (Zhang et al. 2009). Among those 
genes, a very important target of nuclear Ca2+ is the nuclear Ca2+/ calmodulin-
dependent protein (CaM) IV and the transcription factor cyclic-AMP response 
element binding protein (Hardingham & Bading, 2010). Synaptic NMDA receptor 
activity promotes neuroprotection throughout the activation of pro-survival signalling 
pathways, including cAMP response element-binding protein-dependent (CREB-
dependent) gene expression (Soriano et al. 2006). CaM kinase IV is an important 
regulatory protein (Enslen et al. 1994) and CREB is the prototypical signal-regulated 
transcription factor. CREB is a central mediator of neuroprotection being responsible 
for controlling a number of pro-survival genes (Zhang et al. 2005). In hippocampal 
neurons, CREB-dependent gene expression is linked with long-lasting activity-
dependent neuroprotective episodes against apoptotic and excitotoxic insults 
(Hardingham & Bading, 2010). This acquired and long-lasting form of 
neuroprotection depends on Ca2+ nuclear signalling (Hardingham & Bading, 2010). 
Through intracellular calcium level manipulations, it has been shown that Ca2+ has a 
main role in CREB activation (Hardingham et al. 2001). This neuroprotection arises 
due to the strengthening of the mitochondria against cellular stress and oxidative or 
toxic insults (Zhang et al. 2009).  
Oxidative stress manifestation is related with an imbalance between reactive 
oxygen species (ROS) and cellular ability to neutralize them via intrinsic antioxidant 
defences. Neurons are a particularly susceptible and vulnerable type of cell 
concerning oxidant damage due to high formation of reactive oxygen species. The 
oxidative damage has a cumulative effect throughout aging and is now recognized as 
a major accountable factor for some neurodegenerative diseases as well as acute 
cerebrovascular disorders (Papadia et al. 2008). In addition to apoptosis-suppression 
effects, synaptic NMDA receptor activity also displays a key role in enhancing 
neuronal antioxidant defences (Hardingham & Bading, 2010). Synaptic NMDA 
receptor activity triggers signalling changes centred on the thioredoxin-peroxiredoxin 
system that underlie a coordinated program of gene expression changes that 
ultimately lead to the enhancement of antioxidant effects (Papadia et al. 2008).  
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Ultimately, the expression of these genes will contribute to the preservation of 
normal neuronal functions and in the improvement of cellular viability when facing 
aggressive stimuli (Hardingham & Bading, 2010). Also, they can regulate the 
development and function of individual synapses contributing to synaptogenesis 
(West et al. 2002). In the context of synaptic plasticity, CREB plays a central role in 
prolonging and consolidating activity dependent changes in synaptic strength 
(Papadia et al. 2005). Another target of nuclear Ca2+ - CREB signalling is a gene that 
encodes the neurotrophin brain-derived neurotrophic factor (BDNF) (Hardingham & 
Bading, 2010), which is strongly regulated by synaptic NMDA receptor activity 
(Hardingham et al. 2002). Besides showing neuroprotective proprieties, lowered 
BDNF expression plays an important role in neurodegeneration processes that follow 
NMDA receptor blockade (Hansen et al. 2004). BDNF can rescue neurons from 
NMDA blockade-induced neuronal cell death (Hardingham & Bading, 2010).  
The suppression of neuronal death promoting genes consists in a second 
mechanism through which synaptic NMDA activity guarantees neuronal cell health 
(Hardingham & Bading, 2010). As said, long-lasting activity-dependent 
neuroprotection is triggered by Ca2+ entry through synaptic NMDA receptors, 
requiring the propagation of calcium signals into the nucleus and initiation or 
repression of gene transcription (Lau & Bading, 2009). Transcriptional suppression of 
core components of the intrinsic apoptosis cascade is regulated by nuclear Ca2+ 
signalling (Hardingham & Bading, 2010). Generation of neuronal apoptosis can occur 
through up-regulation of BH3-only genes such as Puma (Léveillé et al. 2010). It is 
known that synaptic NMDA receptor activity can supress the expression of this 
specific gene, both in vitro and in vivo. Similarly to the activation of CREB, 
suppression of Puma is also specifically induced by synaptic NMDA receptor 
activity. Ultimately, the suppression of these genes expression results in apoptosis 
inhibition, increasing neuronal viability (Hardingham & Bading, 2010). Also, the 
tumour suppression gene, trp53 and two of its targets are regulated by synaptic 
NMDA receptor activity. Suppression of trp53 acts mutually with nuclear activity and 
nuclear calcium-induced neuroprotective genes and jointly promotes neuronal 
surviving through inhibition of mitochondria permeability transition (Lau & Bading, 
2010). Mitochondrial health improvement represents a key factor in neuroprotective 
synaptic NMDA receptor activity mediated pro-survival signalling (Lau & Bading, 
2010). Synaptic NMDA receptor activity also subdues the expression of important 
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pro-death transcription factors such as the FOXO family of Forkhead transcription 
factors (Hardingham & Bading, 2010). FOXO dependent cellular responses include 
gluconeogenesis, neuropeptide secretion, atrophy, autophagy, apoptosis, cell cycle 
arrest and oxidative stress (Salih & Brunet, 2008). The inhibition of FOXO nuclear 
import is long lasting (Al-Mubarak et al. 2009), which means that it can be sustained 
for a considerable period of time, even after synaptic NMDA activity has ceased 
(Hardingham & Bading. 2010).  
Also, activation of synaptic or extrasynaptic NMDA receptors that contain in 
their composition GluN2A subunits is correlated with neuronal survival promoting 
mechanisms. Furthermore, these receptors can function as a neuroprotective agent 
against neuronal damage provoked by NMDA receptors or other brain components 
(Liu et al. 2007).  
 
2.4.2 - Extrasynaptic pro-death signalling pathways        
 
Neuronal death dependent from NMDA receptor activity can be mediated by a 
variety of signalling pathways that are related to the cell type, the developmental 
stage or the intensity of the excitotoxic insult. Compared to synaptic NMDA receptor 
activity, extrasynaptic NMDA receptor activity has been shown to be highly 
associated with certain pro-death signalling pathways (Hardingham & Bading, 2010).   
In direct contrast to what was referred just before, an episode of extrasynaptic 
NMDA receptors activity promotes CREB inactivation and excitotoxicity events such 
as mitochondrial depolarization in hippocampal neurons (Soriano et al. 2006). 
Moreover, CREB dephosphorylating induced by extrasynaptic NMDA receptor 
activity superimposes CREB activating signals (Sala et al. 2000). The extrasynaptic 
complexes can act as an antagonist towards nuclear signalling pathways to CREB, 
blocking the induction of BDNF expression resulting in mitochondrial dysfunction 
and neuronal cell death (Hardingham et al. 2002).  
Investigation in the last two decades has proved that calcium influx into 
neurons through voltage-gated or ligand-gated ion channels does not imply 
necessarily a unique and pre-ordained response from the cell. In fact, neurons are 
wired in complex ways, allowing them to respond differently to calcium signals with 
distinct characteristics. These crucial parameters include a variety of calcium signal 
features such as magnitude, spatial properties, oscillatory frequency and the channel 
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through which the calcium initially flows into the neuron (Hardingham & Bading, 
2002).  
Different channels are associated with different signalling molecules or 
adaptors that can be specifically activated when calcium signals flows through those 
specific channels. An overwhelming example of calcium entry site-specific 
differences is the regulation of transcription mediated by the CREB-binding protein 
CREB (Hardingham & Bading, 2002). Synaptic and extrasynaptic NMDA receptors 
are coupled to survival and cell death pathways respectively. These differences are 
explained mainly due to their opposing effects on the cAMP response element 
binding protein (CREB) (Bengston et al. 2008). CREB regulates the expression of 
many proteins, including neurotrophic factor BDNF. This protein is highly studied in 
neuronal plasticity field of investigation due to its engagement in both early and late 
phases of LTP. Also, a polymorphism of the gene that encodes BDNF is linked to 
impaired episodic memory in humans, underlying the possible relevance for BDNF in 
cognitive functions (Vanhoutte & Bading, 2003). In experiments using bath glutamate 
it was shown that this condition fails to increase BDNF expression due to shut-off of 
CREB activity, triggered by extrasynaptic NMDA receptors activated by glutamate 
(Sala et al. 2000). CREB shut-off is induced by a rapid dephosphorylation of its 
active-site amino acid, serine 133 (Vanhoutte & Bading, 2003). The duration over 
which serine 133 remains phosphorylated affects considerably the degree of CREB-
dependent transcription. The dephosphorylation of CREB on serine 133 blocks 
CREB-dependent reporter gene expression that is initiated by calcium influx through 
either L-type channels or synaptic NMDA receptor activity. This way, the observation 
that bath glutamate rarely promotes CREB activation being, on the other hand, highly 
associated with CREB dephosphorylation can be explained by the dominance of 
extrasynaptic NMDA receptor activity over synaptic NMDA receptors signalling 
(Hardingham & Bading, 2002).   
 Synaptic and extrasynaptic NMDA receptor signalling triggers completely 
different processes. In fact, synaptic and extrasynaptic NMDA receptors stimulate or 
inhibit the expression or suppression of the same genes or processes in an opposing 
way. Figure 2.4.2.1 summarizes the different signalling pathways induce by synaptic 
and extrasynaptic NMDA receptor activity.     
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Figure 2.4.2.1 – Summarizing the different signalling pathways induced by synaptic vs. 
extrasynaptic NMDA receptor activity. Based on Hardingham & Bading, 2010 review.  
 
2.5 - Neuromodulation 
 
Traditionally, the communication between neurons within a neuronal circuitry 
has been thought to implicate classical neurotransmission. In this classic form of 
communication, one neuron either inhibits or excites the other neuron with which it 
synapses on (Katz & Frost, 1996). Neurons communicate directly with each other by 
chemical synaptic transmission across synapses. Generally, neurotransmission acts 
through ligand-gated ion channels and the neurotransmitters involved in synaptic 
transmission are though to mediate brief postsynaptic responses that are spatially 
restricted. However, some of these agents can also modulate pre and postsynaptic 
responses without necessarily evoking postsynaptic potentials. Neuromodulation 
differs from neurotransmission in that it does not necessarily implicate excitation or 
inhibition from one neuron to another (Katz & Frost, 1996). Neuromodulators act 
through intracellular second messenger cascades that origin slower, spatially diffused 
and long-lasting responses (Gelinas & Nguyen, 2007), which alter the cellular or 
synaptic proprieties of neurons (Katz & Frost, 1996). Anatomic wired clusters of 
neurons in the central nervous system can be reconfigured by neuromodulators. These 
neuron clusters are responsible for the formation of networks that will produce 
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specific rhythmical patters of activity (Pflüger, 1999). In figure 2.5.1 are represented 
tow second messenger system that are relevant to this work.  
 
Figure 2.5.1 – Simplified reaction schemes of two messenger systems of interest to this work. In 
the left: The adenylate cyclase/cyclic AMP-dependent protein kinase system. Adenosine receptors are 
known to couple with G proteins that, depending of the adenosine subtype receptor, either inhibit (van 
Calker et al. 1979) or stimulate (Corvol et al. 2001) the expression of adenylate cyclase. In the right: 
Intracellular calcium ions as second level messengers. NMDA receptor activity is particularly linked 
with Ca2+ influx inside the postsynaptic cell being associated with a large variety of intracellular 
signalling pathways dependent on Ca2+ influx variations, as LTP induction (Malenka & Nicoll, 1999). 
Drawings adapted from Kaczmarek & Levitan, 1987.    
 
The concept of neuromodulation was initially recognized as a mechanism 
where an endogenous substance, which could be released from the pre or postsynaptic 
component, influences the release (presynaptic modulation) or the action 
(postsynaptic modulation) of the neurotransmitter (Sebastião & Ribeiro, 2009). 
Described in a restricted way, neuromodulation can be defined as the neuronal ability 
to change electrical proprieties in response to intracellular biochemical changes 
resulting from synaptic or hormonal stimuli (Kaczmarek & Levitan, 1987). Figure 
2.5.1 displays some of the changes that the neuromodulators can produce upon the 
electrical properties of neurons.  
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Figure 2.5.2 – Some of the changes that can be observed in the electrical properties of neurons. 
A) Alterations in the shape of action potentials; B) Changes in frequency and pattern of firing; c) 
Inhibition and onset of bursting; D) Changes in response to stimulation (arrow). Taken from 
Kaczmarek & Levitan, 1987.  
 
Neuromodulators can modify neural processing in many different ways 
regulating various neurophysiological processes (Stern et al. 2007). Therefore, they 
can affect the integrative proprieties of neurons, by altering the way through which 
they respond to synaptic drive, modify the strengths of the synaptic interconnections 
(Sillar et al. 2002) and reshape the plasticity of those synapses (Dayan, 2012). By 
changing the properties of neurons, neuromodulators can reshape the output of a 
circuit (Katz & Frost, 1996) and reconfigure the network, producing different output 
patterns, hence, making the network multifunctional (Pflüger, 1999).  By doing so, 
neuromodulation allows the central nervous system to adapt its control of 
psysiological functions to a continually changing environment (Kaczmarek & 
Levitan, 1987). Biochemical changes that lead to modifications in the electrical 
features of a neuron may be triggered in one of three ways: by the action of 
neurotransmitters at specific synaptic junctions, by neurotransmitters secreted at less 
specialized release sites at a distance from the target neuron and finally, through the 
action of hormones (Kaczmarek & Levitan, 1987).  
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Figure 2.5.3 – Stimuli that can modulate neuronal activity. 1) Synaptic release of neurotransmitter; 
2) Local release of agents from neuronal processes not in direct contact with the target cell; 3) Actions 
of hormones released from other tissues. Taken from Kaczmarek & Levitan, 1987.  
 
Previously, neuronal interaction diagrams rarely incorporated 
neuromodulation, including only fast synaptic contacts. First, neuromodulation was 
usually viewed as being originated from a source extrinsic to the circuit and therefore 
not a part of the circuit itself. Secondly, even when neuromodulatory interactions are 
intrinsic to the neuronal circuit, these interactions can easily be overlooked because of 
their slow time course or because their effects are contingent upon the activity of the 
neurons in which they act (Katz, 1995). Yet, it is now establish that both intrinsic and 
extrinsic neuromodulation are important for neuronal circuits control. It is important 
to distinguish intrinsic from extrinsic neuromodulation to fully comprehend 
neuromodulatory functions in the operation of neuronal circuits. In extrinsic 
neuromodulation, a circuit receives modulatory inputs from neurohormones or other 
areas of the nervous system. Due to its location outside the circuits that it affects, a 
single extrinsic source can modulate different circuits simultaneously. Additionally, a 
single circuit can receive extrinsic neuromodulatory inputs from several different 
sources, allowing the circuit do be differentially modulated under different conditions 
(Katz, 1995). Intrinsic modulation it is not optional, rather mandatory. Moreover, by 
contrast with extrinsic neuromodulation, within intrinsic neuromodulation the 
neuromodulatory substances are released by neurons that are intrinsic to a circuit, 
being able to affect other neurons and synapses in the same circuit (Katz & Frost, 
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1996). Additionally, the amount of neuromodulatory agents release is controlled by 
activity within the circuit itself, not by the activity of a distant region or structure in 
the nervous system (Katz, 1995). Consequently, intrinsic neuromodulation occurs 
whenever the circuit is activated and the level of intrinsic neuromodulatory action 
reflects the intensity of the activity in the circuit itself (Katz & Frost, 1996). Figure 
2.5.4 presented below displays the main differences between both types of 
neuromodulation.  
 
  
Figure 2.5.4 – Extrinsic and intrinsic neuromodulation. Schematics on the left represent extrinsic 
neuromodulation originated from neurons outside the local circuit. Different neuromodulatory neurons 
can be active at different times and in different behavioural contexts. Also, a single neuromodulatory 
neuron can elicit neuromodulatory effects in many different circuits simultaneously. On the other hand, 
the schematics on the right panel of the figure represent intrinsic neuromodulation that arises from the 
activity of neurons within a circuit itself. These neuromodulatory effects are always present whenever 
the circuit is active. Adapted from Katz & Frost, 1996.  
 
2.5.1 - Adenosine as a neuromodulator  
 
Among the diversity of neuromodulators existent in the nervous system, 
adenosine and ATP are key fine-tuners for three main reasons. First, they are among 
the most significant components in communication processes between neurons and 
glia cells. Secondly, adenosine and ATP can affect the release and action of several 
neurotransmitters and neuromodulators. Finally, adenosine and ATP can be release by 
almost all cells in the nervous system (Sebastião & Ribeiro, 2009). Purines and purine 
nucleotides are vital components of all living cells. ATP is used as an energy source 
in virtually all cellular activity and adenine is a component of nucleic acids. Due to 
their ubiquitous nature, purines are also a very important component for both 
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intracellular and extracellular signalling (Dunwiddie & Masino, 2001). While ATP 
can work as a neurotransmitter in some brain regions (Burnstock, 2007), adenosine is 
neither stored nor released as a classic neurotransmitter since it does not accumulate 
in synaptic vesicles. Adenosine is directly released from the cytoplasm to the 
extracellular space through a nucleoside transporter. Since it is not exocytotically 
released, adenosine acts as extracellular signalling molecule that modulates synaptic 
transmission without being a neurotransmitter (Sebastião & Ribeiro, 2009), just as it 
does in other excitable tissues, such as the heart, where its actions were first described 
(Drury & Szent-Györgyi, 1929). Many adenosine actions both inhibit and reduce the 
activity of excitable tissues or upsurge the delivery of metabolic substrates, helping 
coupling the energy expenditure to the energy supply (Dunwiddie & Masino, 2001). 
Adenosine acts as a potent neuromodulator in the central nervous system 
modulating synaptic activity (Jenner et al. 2009) and modulates neuronal activity 
through G-protein-coupled mechanisms that lead to changes in second-messenger 
levels and modulation of ion channels. Adenosine modulatory effects can occur 
presynaptically, by inhibiting or facilitating transmitter release, postsynaptically, 
through modifications in other neurotransmitters actions, and nonsynpatically by 
hyperpolarizing or depolarizing neurons (Sebastião & Ribeiro, 2009). Adenosine 
concentration can upsurge either through an increase in intracellular formation or 
through the increase in adenosine nucleotides release followed by their rapid 
degradation. Increased intracellular adenosine formation results mainly from an 
imbalance between energy supply and activity demands (increases in cellular activity 
or hypoxia episodes, for instance) that lead to degradation of adenosine triphosphate 
(ATP) and in an increase in adenosine monophosphate that is easily broken down to 
adenosine (Jenner et al. 2009). Biochemical studies suggest that adenosine 
nucleotides are a potential source of extracellular adenosine formation, mainly 
through ATP molecules that are released as a transmitter or from damaged cells 
(Dunwiddie et al. 1997).  
 
2.5.2 – Adenosine receptors 
 
The biological effects of adenosine are mediated by four distinct subtypes of 
G-protein-coupled cell surface receptors (Tsutsui et al. 2004). Adenosine subtype 
receptors are found throughout the brain and are implicated in diverse neurological 
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functions and pathologies (Lusardi, 2009). A1, A2A, A2B and A3 receptors (A1Rs, 
A2ARs, A2BRs and A3Rs) are the four different adenosine receptor subtypes that have 
already been successfully cloned and pharmacologically characterized in several 
species (Wirkner et al. 2004). Adenosine receptor expression throughout the brain is 
region-specific (Ribeiro, et al. 2002) and varies through brain development (e.g. Shaw 
et al. 1984). A1 and A3 adenosine receptors are respectively coupled do Gi and Go, 
proteins known to inhibit the expression of adenylate cyclase (van Calker et al. 1979), 
while A2A and A2B receptors are coupled to Gs proteins, known to stimulate the 
expression of adenylate cyclase and to raise intracellular levels of cAMP (Corvol et 
al. 2001). All adenosine receptor subtypes are implicated in the regulation of 
immunomodulatory molecules synthesis and release (Tsutsui et al. 2004). 
Importantly, while A1 and A2A subtype receptors display high affinity for adenosine 
and are excepted to exert important regulatory functions in physiological conditions, 
A2BRs and A3Rs are low-affinity receptors most likely to play a role in pathological 
conditions featuring increased extracellular concentrations (Dunwiddie & Masino, 
2001). The higher density of A1 and A2A subtype receptors in the brain and the 
modest impact upon brain functions of A2BRs and A3Rs pharmacological 
manipulation, has led to the idea that adenosine influence in brain functions might 
mostly depend on the actions of A1Rs and A2ARs (Gomes et al. 2010). A1Rs and 
A2AR are vastly expressed in several brain areas (Lusardi, 2009), as it is possible to 
observe in figure 2.5.2.1 displayed below. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.1.1 – Distribution of adenosine receptors in the rat brain. Higher levels of expression 
are indicated by larger alphabets. Adapted from Ribeiro et al. 2003 
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 A1 receptors are highly expressed in the cerebral cortex, while A2A receptors 
are strongly expresses by straitopallidal GABAergic neurons and are found at much 
lower levels in other brain regions (see Ribeiro et al. 2003), namely the hippocampus. 
A1R is the adenosine subtype receptor that can be found in almost all brain regions 
being associated with K+ and CA2+ channel activation, both related to neuronal 
activity inhibition (Dunwiddie & Masino, 2001). On the other hand, A2A receptors are 
expressed in high levels only in some restricted brain regions, namely the striate and 
other basal ganglia structures (Haas & Selbach, 2000). Figure 2.5.2.2 shows the 
affinity of each subtype of adenosine receptor and the G-protein protein to which each 
one of them couples. It is possible to see that both A1 and A2A receptors display high 
affinities when compared with A2B and A3 receptors. Also, it demonstrates the main 
effects that result from the coupling of adenosine receptors to the specific G-proteins. 
Adenosine A2A receptors are usually coupled to Gs proteins that trigger cAMP 
formation and lead to PKA activation (Fredholm et al. 2001). On the contrary, A1Rs	  
are mainly associated to Gi proteins that decrease cAMP formation. Increases in 
cAMP formation and PKA activation are important to synaptic plasticity processes, 
including LTP indcution (Malenka & Nicholl, 1999).  
	  
Figure 2.5.2.2 – Adenosine receptors can couple to several G proteins. Adapted from Dunwiddie & 
Masino, 2001 and Rees et al. 2003.   
  
Adenosine receptors can also influence the action of other neuromodulators 
and ionotropic glutamate receptors such as NMDA receptors as well as metabotropic 
receptors (see Sebastião & Ribeiro, 2000).  
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2.5.3 – A1Rs and A2ARs modulatory actions upon NMDA receptor activity 
 
 Adenosine is capable of both inhibit and excite neurotransmission in the 
central nervous system (Fredholm & Dunwiddie, 1988). Adenosine ability to 
selectively depress excitatory synaptic transmission is the most evident effect of the 
adenosinergic modulation upon synaptic transmission and the one that was primary 
studied and characterized in neuronal circuits (Proctor & Dunwiddie, 1987; 
Thompson et al. 1992). This effect can occur due to pre and post-synaptic 
mechanisms.  
Adenosine application was early identified as capable of reducing transmitter 
release and to depress synaptic potentials (Thompson et al. 1992). In fact, adenosine 
A1 receptors are linked to inhibition in the release of virtually every classic 
neurotransmitter including, among others, glutamate, GABA (γ-Aminobutiric Acid), 
acetylcholine and dopamine. However, the most prominent adenosine inhibitory 
actions are generally exhibited at glutamatergic excitatory systems. In some cases, 
adenosine can completely block synaptic transmission upon excitatory glutamatergic 
transmission.  
Activation of adenosine A1 receptors shows the ability to induce 
neuroprotective actions in ischemia models as well as neuromodulatory effects on 
synaptic transmission through inhibition of neurotransmitter release (Barrie & 
Nicholls, 1993) and by reducing long-term changes in synaptic efficiency (de 
Mendonça & Ribeiro, 1997). The mechanism of inhibitory modulation of transmitter 
release has been vastly studied and appears to reflect a G-protein-coupled inhibition 
of Ca2+ channels in nerve endings (Dunwiddie & Masino, 2001). More recently, the 
low release probability of excitatory synapses was linked with a tonic presynaptic 
activation of A1 receptors mediated by ambient adenosine. Indeed, the removal of 
extracellular adenosine or the inactivation of A1 presynaptic receptors with 
antagonists drastically augments synaptic transmission. Additionally, tonic 
presynaptic activation of A1 receptors also impairs LTP and NMDA receptor-
dependent forms of plasticity (Moore et al. 2003). The inhibitory action of adenosine 
A1 receptors upon pre-synaptic glutamate release is schematized in figure 2.5.3.1 
displayed below.  
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Figure 2.5.3.1 – Presynaptic modulatory action of adenosine A1 receptors. Inhibition of transmitter 
release, namely glutamate, selectively depresses excitatory synaptic transmission (Proctor & 
Dunwiddie, 1992; Thompson et al. 1992) 
 
When considering more integrative properties of neuronal circuits, 
postsynaptic sites of action also have to be accounted. Thus, A1 postsynaptic receptor 
activation stimulates potassium conductance leads to neuronal hyperpolarization and 
controls neuronal firing (Greene & Haas, 1991). Also, A1 receptors located at the 
postsynaptic density can influence neuronal responsiveness to excitatory stimuli 
through a simultaneous control of N-type calcium channels and NMDA receptors 
(Gomes et al. 2010). These findings reinforced the idea that the adenosinergic 
modulatory role upon NMDA receptor contributions for plasticity and long-lasting 
plasticity (de Mendonça & Ribeiro, 1997; Klishin et al. 1995). In such investigations, 
it was found that the external application of an adenosine A1 receptor antagonist 
increased both the amplitude of excitatory postsynaptic currents and the NMDA 
receptor-mediated component for the currents (Klishin et al. 1995). In isolated rat 
hippocampal neurons, adenosine A1 receptor activation inhibits NMDA receptor-
mediated currents (de Mendonça et al. 1997). Furthermore, this effect occurs at very 
low concentrations of A1 agonist, which may imply that there is a tonic inhibitory 
action of adenosine (Sebastião & Ribeiro, 2009). Accordingly, when an A1 receptor 
antagonist is used, NMDA receptor-mediated currents increase, probably due to the 
recruitment of previous silent NMDA receptors (Klishin et al. 1995). Apparently, 
endogenous adenosine, through a postsynaptic action, is capable of inhibiting voltage 
and NMDA receptor-sensitive dendritic spikes in CA1 population of neurons (Li & 
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Henry, 1998). These postsynaptic actions upon NMDA receptor activity together with 
the ability of A1 receptors to inhibit glutamate release, are the basis for the adenosine 
A1 receptor mediated inhibition of synaptic plasticity phenomena in CA1 and CA3 
neuronal populations (Sebastião & Ribeiro, 2009), as it is possible to see in the 
schematics displayed in figure 2.5.3.2.  
 
Figure 2.5.3.2 – Postsynaptic modulatory action of adenosine A1 receptors. A1 receptors stimulate 
potassium conductance and effectively control the amplitude of synaptic plasticity in excitatory circuits 
(Green & Haas, 1991).  
 
During several years the research on A2A adenosine receptor actions in brain 
function was clouded due to the prominent inhibitory role of adenosine in the control 
of basal synaptic transmission. The lack of research on A2A receptors was further 
aggravated by the widespread idea that the distribution of these receptors was limited 
to specific cerebral areas, namely the striatum (Svenningsson et al. 1999). Albeit their 
distribution in extra-striatal areas appears to be significantly lower than in the 
striatum, A2A receptors are widely spread in the brain, especially in the synapses 
(Sebastião & Ribeiro, 1992) and dopamine-enriched areas (Svenningsson et al. 1997). 
After discovering that A2A receptors are expressed in extra-striatal areas, the research 
of the actions of these receptors upon synaptic transmission increased significantly 
and new modulatory actions of these receptors were rapidly found. Although these 
receptors show a limited impact on the control of basal synaptic transmission, they are 
crucial in controlling synaptic plasticity (Cunha et al. 2008). In contrast with their 
modest role in the control of neurotransmitter release, presynaptic A2A receptors 
effectively modulate the action of several receptors. This led to the suggestion that 
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adenosine A2A receptors mostly behave as regulators of other modulatory systems 
(Lopes et al. 1999).  
A2A adenosine receptors were found in the rat hippocampus, where it was also 
observed the binding of specific A2A receptor agonist CGS 21680 (Cunha et al. 1996). 
Accordingly, more recently it was established that CGS 21 680 has excitatory effects 
on hippocampal pyramidal cells and that are blocked by adenosine A2A receptor 
antagonist DMPX (Li & Henry, 1998). In addition to data that demonstrated similar 
results in hippocampal population spikes (Sebastião & Ribeiro, 1992), these results 
were the first ones suggesting that the excitatory roles of adenosine are mediated via 
activation of A2A receptors. Also, these data postulated in first hand that the excitatory 
effects of A2A receptors are expressed via both presynaptic and postsynaptic adenosine 
receptor activation (Li & Henry, 1998).  
At a presynaptic level, A2A receptors are known for playing a facilitatory role 
upon glutamate release (Lopes et al. 1999). Due to a tight A1-A2A receptor interaction 
(Lopes et al. 1999), it was fairly unclear whether the excitatory role of A2A receptors 
was to directly control neurotransmitter release or, alternatively, to attenuate the tonic 
inhibition mediated via adenosine A1 receptor activation.  
 
Figure 2.5.3.3 – Presynaptic actions of adenosine A2A receptors. Presynaptic A2A receptors can 
facilitate glutamate release into the synaptic cleft, only when a tonic A1 receptor-mediated inhibition is 
present. 
As it is possible to see in figure 2.5.3.3, nowadays it is known that the 
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specific agonists it is not a direct effect but rather a consequence of a presynaptic 
attenuation of A1 receptor response (Lopes et al. 2002). Attenuation of A1 receptor 
inhibition seams to constitute a fine-tuning mechanism that allows frequency-
dependent phenomena without compromising the A1 receptor-mediated 
neuroprotective role (Lopes et al. 2002).   
At a postsynaptic level, adenosine A2A receptors also display a role in the 
modulation of excitatory synaptic transmission. The modulation of NMDA receptor 
activity is of particular interest to this work and it has been a subject recently 
investigated, especially due to the consequences of NMDA receptor activation for 
synaptic plasticity processes. It is known that the pharmacological activation of 
adenosine A2A receptors regulates NMDA receptor function in the striatum (Tebano et 
al. 2005, Wirkner et al. 2004). Also, it was recently shown that there are forms of 
LTP that are mediated by postsynaptic NMDA receptor activity at mossy fibers 
synapses (Rebola et al. 2008). This form of LTP is dependent of elevations in 
intracellular Ca2+ inside the postsynaptic neuron, requiring the co-activation of 
NMDA receptors and metabotropic glutamate receptor 5 (mGluR5) in addition to 
adenosine A2A receptors (Rebola et al. 2008).  Given the role of NMDA receptor 
activity in synaptic plasticity, memory formation and spatial learning, these results 
show that postsynaptic adenosine A2A receptors may potentially affect information 
processing in CA3 neuronal networks and memory performance. 
 
Figure 2.5.3.3 – Postsynaptic actions of adenosine A2A receptors. Modulatory effects of A2A 
receptors upon NMDA receptor activity at the mossy fibers (Rebola et al. 2008). 
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Whether A2A receptors modulate the activity of NMDA receptor in the 
hippocampus is still unclear and comprises the main objective of the present work.   
Summarizing, at the hippocampus adenosine A2A receptors are located at 
presynaptic and postsynaptic levels, where they control several key processes for 
synaptic plasticity and memory formation. Indeed, adenosine A2A receptors are known 
to directly control the release of glutamate (Lopes et al. 2002) as well as the 
activation of glutamate receptors, such as AMPA receptors (Dias, et al. 2012). This 
work was developed with the main objective of understanding if the activation of 
excitatory adenosine A2A receptors could also modulate the activity of glutamate 
NMDA receptors at CA1 pyramidal cells. To achieve these goals, it would be 
important to create experimental conditions that allow discriminating between a pre or 
a postsynaptic modulatory interaction between receptors. For that, the patch clamp 
technique is highly suitable to successfully achieve the objectives proposed for this 
work. 
TECHNIQUES 
3 
 
3.1 – Electrophysiological recordings in hippocampal slices  
3.1.1 – Tissue preparation  
 
The discovery that brain tissues could be isolated and kept alive and healthy 
outside the body, triggered physiologic and pharmacologic research in the nervous 
system. Warburg and colleagues initiated metabolic brain slices studies in 1924 (see 
Hertz, 2012). In the subsequent decades brain slice preparation was optimized and 
carried on. In 1966, Yamamoto and McIlwain showed that brain slices could display 
synaptic activity. Additionally, Richards and McIlwain showed in 1967 that the 
synaptic activity and excitability of brain tissues kept outside the body in an artificial 
environment (ex vivo) were similar to that observed in in vivo tissues.  
In hippocampal research, the brain slice preparation has been predominantly 
used over the years to study synaptic transmission phenomena in various hippocampal 
neurons and interneurons distributed over different hippocampal populations. The 
hippocampus lies within the medial temporal human lobe showing a distinctive 
curved shape. Its general form is kept among various mammalian species, although its 
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morphology does vary. Hippocampal formation is a bilateral limbic structure that in 
the rat brain has a semi-circular form. Its intact extraction from the brain is very easily 
achieved. Usually, after extraction, both hippocampi are transversely sectioned.  
The internal structure of the hippocampus can be macroscopically described as 
two C-shaped cell layers that are interlocked: the granular cell layer of the dentate 
gyrus and the pyramidal cell layer of the Ammon’s horn (hippocampus proper) and 
the subiculum (Lopes da Silva et al. 1990). The hippocampus proper is composed of 
various subfields. The cornus ammonis (CA1) is generally differentiated into CA1, 
CA2 and CA3 areas and it showing seven clearly defined depth layers: stratum 
moleculare; stratum lacunosum; stratum radiatum; stratum pyramidale (the principal 
cell layer); stratum oriens; alveus and epithelium. The dentate gyrus is composed by 
three layers: stratum moleculare; stratum granulosum (principal cell layer) and 
stratum polymorphum. 
 
Figure 3.1.1.1 – Hippocampal anatomy. A) Localization of hippocampus in the rat brain. B) 
Schematic representation of a transversal hippocampal slice with indication of the different areas and 
the main excitatory circuit. C) Representation of a section of CA1 and Dentate Gyrus (DG) area with 
the indication of the different layers. Adapted from Andersen et al., 1971 and Amaral and Witter, 1989. 
Obtained from Rombo, 2009.  
 
Ramon y Cajal first hippocampal drawings showed the major pathways of 
signalling flow through the hippocampal formation. Later, Per Andersen described the 
trisynaptic circuit or trisynaptic loop (Andersen et al. 1971). This loop comprises the 
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hippocampal circuitry that connects the dentate gyrus, CA1 and CA3 areas. From the 
dentate gyrus granule cells, efferent fibers project and send information onto CA3 
pyramidal cells. In turn, these cells send their axons to CA1 pyramidal cells through a 
set of fibers acknowledged as the Schaffer collaterals. From CA1 area, axons project 
mainly to the entorhinal cortex (Dias, 2011).   
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1.2 – Hippocampal structure. The two interlocked “C” shaped curves are well visible. The 
drawing contemplates also the cell types through which information flows to form the trisynaptic 
circuit. DG: dentate gyrus; Sub: Subiculum; EC: entorhinal cortex. This drawing is modified from 
Ramon y Cajal, 1909. Obtained from Dias, 2011.  
 
Per Andersen also found that all the important hippocampal connections were 
maintained when the hippocampus was cut transversally to its long axis (Andersen et 
al. 1969). This was later the basis for the introduction of hippocampal slice 
preparations by Skrede and Westgaard (1971). Hippocampal slice preparations 
preserve the main physiological circuits intact, 400 to 500 µm thick transverse slices 
can keep the tissues alive and healthy for several hours, when properly oxygenated in 
a bath of artificial cerebrospinal fluid. The thinness of the hippocampal slices allows 
the access to the try-synaptic circuit. The hippocampal circuitry and neuronal laminar 
organization is fully preserved and maintained in slices preparation. Hippocampus 
slice preparation has several advantages for the investigator. In the study of central 
nervous system activity, hippocampal slices allow the investigator to directly control 
the surrounding environment of the tissue as well as to apply drugs to the all slice or 
just to specific regions, thus allowing the investigator to directly control and 
manipulate pharmacological tools in known concentrations. These drugs can be 
subsequently washed out or withdrawn at anytime. Also, for electrophysiological 
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procedures, recording and stimulation electrodes can be accurately placed upon 
specific regions of interest. Together with the development of cutting solutions which 
composition minimizes the excitotoxic insult during slice preparation, the 
introduction of vibrating microtomes for tissue processing greatly increased the 
success of patch-clamp recordings from brain slices (see Aitken et al. 1995).  
 
3.1.2 – Patch-clamp techniques 
 
It was in the late seventies that Neher and Sakmann (1976) monitored in first 
hand the opening and closing of single ion channels located in cell membranes 
through conductance measurements. These first recordings of single-cell currents 
were obtained from denervated frog muscle fibers, using glass pipettes of narrow tip 
(Neher & Sakmann, 1976). The investigators noted that when the tip of the pipette 
touched the surface of the cell membrane it developed high resistances, in order of 50 
MΩ. The high resistance between tip and surface was called “seal” and consequently 
patch-clamp was initiated. Briefly after the establishment of this technique, Sigworth 
and Neher (1980) discovered that the appliance of gentle suction to the tip of the 
pipette could create a tight and stable mechanic contact whit a resistance of 10-100 
GΩ (hence, giga-seal). This giga-seal considerably reduced the background noise 
allowing also grater time resolution.  
The high resistance of the seal ensures that virtually all the current from the 
membrane flows into the pipette interior. To obtain a giga-seal became the first and 
mandatory step of patch-clamp recordings. Initially, recordings were obtained from 
the small membrane portion that was pulled inside the pipette after suction appliance. 
This way, it was possible to measure acutely the current flow through the trapped ion-
channels. This patch-clamp configuration received the name of “cell-attached 
recording”. Although there is still a lot of work that it is done in cell-attached mode, 
this configuration cannot provide any information of the resting potential of the cell, 
nor are the extra- or intra-cellular solution changed easily (see Dias, 2011). 
Fortunately it was found that the membrane portion contained inside the pipettes tip 
could be gently removed through the application of more suction. Once this happens, 
the electrode can achieve direct electrical contact with the entire cell interior. 
Consequently, the voltage across all the cell membrane could be clamped, instead of 
just the little portion of the patch. The whole-cell and perforated patch modes allow 
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the measurement of an entire ion-channel population located in the cell membrane, 
therefore giving current flow readings of all cellular activity mediated by the specific 
ion-channels (for review see Liem et al. 1995). This patch-clamp configuration came 
to be known as “whole-cell recording” and is by far the most widely used patch-
clamp configuration. However, it is curious that, by definition, the whole-cell 
configuration does not fit into the strict patch-clamp definition, as in it the clamp is 
applied to the entire cell and not to a small patch of the membrane (Dias, 2011).  
Voltage-clamp procedures are often used to study current flows through 
specific ion-channels. In order to achieve these goals it is very important to 
effectively block undesired currents mediated by ion-channels out of the range of the 
study interest. This can be attained by selectively choosing the ionic composition of 
the bath solution, by controlling the holding potential of the cell membrane or through 
the use of pharmacological tools that specifically block or induce the activity of 
certain individual or group ion-channels (for review see Sontheimer & Olsen, 2007). 
This was the procedure used in this work, where ionic current through NMDA 
receptor ion channels, have been record in the whole cell patch-clamp configuration.   
 
 
 
Figure 3.1.2.1 – Step by step to achieve NMDA receptor-evoked postsynaptic currents 
recordings. Steps 1 to 4: Positioning of the stimulation and recording electrodes and obtaining cell-
attached recording; Step 5 – Patch burst through appliance of more negative pressure obtaini8ng 
whole-cell recording configuration; Step 6 – Stimulation with 2 minute intervaled NMDA puffs and 
recording of the NMDA receptor-evoked postsynaptic currents. 
1) Select CA1 pyramidal neuron 2) Place stimulation electrode  
NMDA (150μM) NMDA (150μM) 
3) Place recording electrode  
4) Obtain a Gigaseal 
The micropippete is pressed against the cell membrane surface 
and suction is applied to assist in the formation of hight 
resistance seal between the glass and the cell membrane.  
A gigaseal is obtained when the electrical resistance in the 
micropipette tip exceeds a gigaohm.    
Cell Attached 
Recording 
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Figure 3.1.2.2 – Step by step to achieve NMDA receptor-evoked postsynaptic currents 
recordings. Step 5 – Patch burst through appliance of more negative pressure obtaini8ng whole-cell 
recording configuration; Step 6 – Stimulation with 2 minute intervaled NMDA puffs and recording of 
the NMDA receptor-evoked postsynaptic currents. 
 
METHODS 
4 
 
4.1 – Animals 
 
 All the experiments were conducted with adult male Wistar rats aged between 
5 and 10 weeks (Harlan Iberica, Spain). The animals were kept under standardized 
temperature, humidity and lighting conditions, according to Portuguese Legislation. 
Animals were housed in the local Animal House in 12 hours light/dark cycle and were 
provide with food and water ad libitum. For ethical reasons, care was taken in order to 
assure that the number of rats utilized during this investigation was the smaller 
possible. 
 
 
5) Obtain whole cell configuration 
More negative pressure is applied with the intuit of bursting 
the membrane portion inside the micropipette. 
Membrane rupture creates a larger opening at the tip of the 
electrode, providing lower resistance and thus better access to 
the inside of the cell. By doing so it becomes possible to record 
currents through multiple channels at once, reflecting the 
activity of all the cell.   
Whole-Cell 
Recording 
6) Induce NMDARs activity through stimulation 
NMDA (150μM) 
2 minute intervaled puffs  
The recording electrode registers the NMDA evoked currents.   
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4.2 – Preparation of hippocampal slices for electrophysiological recordings 
 
 Before dissection the animals were anesthetized with Isoflurane (in 1,2-
Propylenglycol 50% (v/v)) in a proper anesthesia chamber. To assure that the animal 
is properly anesthetized the animal behavioural responses were observed. The first 
indications of anesthesia include the lack of movement and the slow respiratory rate. 
The skin was then pinched and the absence of movement reflected deep anesthesia. 
However, it is very important that the animal does not die under anesthesia, since it 
would exacerbate neuronal cell death processes, by decreasing the time window 
between sacrifice, brain extraction and its placement in a artificial cerebrospinal fluid 
solution. After proper anesthesia the animal was sacrificed by decapitation in a 
guillotine. Subsequently, the brain was rapidly extracted from the skull and placed in 
an oxygenated iced artificial cerebrospinal solution (aCSF solution) with the 
following composition (in mM): sucrose 110; KCl 2.5; CaCl2 0.5; MgCl2 7; NaHCO3 
25 NaH2PO4 1.25; glucose 7, oxygenated with 95% O2 and 5% CO2, pH 7.4. Together 
with use of this solution, a quick dissection under low temperature reduces the 
probability of neuronal cell death, increasing the viability of the tissue and cells. After 
the brain was extracted and hemisected, both hippocampi were dissected and used to 
obtain 300µm thick transversal slices cut on a vibrating microtome acknowledge as 
Vibratome (VT1000 S; Leica; Germany) in the same ice cold dissecting aCSF 
solution.  
 After both hippocampi were cut on the Vibratome the slices were incubated 
for 30 minutes in a 35ºC aCSF bath solution containing (in mM): NaCl 124; KCl 3; 
NaH2PO4 1.25; NaHCO3 26; MgSO4 1; CaCl2 2 and glucose 10, pH 7.4, gassed with 
95% O2 and 5% CO2. After the 30minute window time, the slices were withdrawn 
from the 35ºC bath and placed in recovering at room temperature for at least one hour.  
 Another solution was prepared for use during the patch-clamp procedures with 
the following composition (in mM): NaCl 124; KCl 3; NaH2PO4 1.25; NaHCO3 26; 
Glycine 5; CaCl2 2 and glucose 10, pH 7.4. The composition of this solution was very 
similar to the recovery one, except that it did not included MgSO4. The omission of 
Mg2+ was required NMDA receptors are blockade by extracellular magnesium, 
whenever the membrane potential is close to the resting state. Indeed, in experiments 
conducted using the standard aCSF solution, the NMDA receptor evoked postsynaptic 
potentials were almost inexistent at membrane potentials of -60 mV. Upon the 
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withdrawn of Mg2+ and the inclusion of glycine (NMDA receptor co-agonist) it was 
possible to record NMDA receptor evoked postsynaptic potentials.  
 After the recovery period the slices were ready to be used in patch-clamp 
techniques. For that, individual slices were fixed with a grid in a recording chamber 
(5-6mL) and continuously superfused by a gravitational superfusion system at 2-
3mL/min with aCSF (with glycine and without Mg2+) at room temperature. The 
pharmacological tools added during the procedure reached the slice within 2 or 3 
minutes after its application.  
 Whole-cell recordings were obtained from CA1 pyramidal cells. CA1 
pyramidal cells were visually identified using a Carl Zeiss Axioskop 2FS upright 
microscope (Jena, Germany) equipped with infrared video microscope and 
differential interference contrast optics. Just to ensure that the cells recorded were in 
fact CA1 pyramidal cells at the beginning of some experiences a fire-pattern was 
routinely performed. Pyramidal cells are known to express a slow fire frequency 
(≤5Hz), longer action potentials (≥0,8ms) and featuring spike-frequency adaptation.  
 Patch pipettes were made from borosilicate glass capillaries (1.5mm outer 
diameter, 0.86 inner diameter, Harvard Apparatus) on a pipette puller (PC-10 Puller, 
Narishige Group). The resistances of the recording electrodes/pipettes varied between 
4 and 9MΩ, with its optimal resistance located in 6-7MΩ. To patch the cell the 
pipettes were filled with an intracellular solution containing in its composition the 
following (in mM): K-gluconate 125; KCl 11; CaCl2 0.1; MgCl2 2; EGTA 1; HEPES 
10; MgATP 2; NaGTP 0.3 and phosphocreatine 10, pH 7.3, adjusted with KOH (1M), 
280-290mOsm.  
Whole-cell NMDA-evoked postsynaptic currents (PSCs) were recorded in a 
voltage-clamp mode (Vh =-60mV) with an EPC-7 amplifier (List Biologic, Campbell, 
CA). Offset potentials were nulled directly before giga-seal formation. The holding 
current was monitored throughout the experiment and when this parameter varied by 
more than 20%, the experiment was rejected. Voltage errors caused by small changes 
in input resistance were not corrected. The current signal was filtered using a 3 and 10 
kHz three-pole Bessel filter of an EPC-7 (List Medical) amplifier. 
NMDA receptor-mediated currents were evoked using a pressure ejection 
system (PicoPump PV820; World Precision Instruments). A micropipette containing 
NMDA (150µM) was positioned near the recording cell and pulses of pressure were 
applied (10ms puffs, 6-10psi, applied at 2min intervals). The experimental protocol 
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was initiated at least 30min after the whole-cell formation in order to assure the 
stabilization of the elicited currents. Application of a selective NMDA receptor 
agonist (NMDA 150µM) through 2min intervaled puff stimulation onto the soma of 
CA1 pyramidal cells was used to evoke currents that reflected the activity of NMDA 
receptors. This kind of protocol has the advantage of allowing the subsequent 
application of pharmacological tools of interest. In this case, selective adenosine A2A 
receptor agonist and antagonist (CGS 21680 and SCH 58261, respectively), specific 
NMDA receptor antagonist (DL-APV) and the competitive antagonist of other 
glutamate receptors, such as kainate and AMPA were applied. The continuous 
measurement of NMDA receptor-evoked postsynaptic currents throughout the 
experiment guarantees that any effect observed upon the registered currents is a 
consequence of the drug being applied. Panels A, Band C displayed in figure 4.2.1 
show the placement of the recording and stimulation electrodes first in CA1 
hippocampal region and then patching a pyramidal neuron. Panel D displays an 
example of a NMDA-evoked PSCs recorded during the procedure.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.1 – Patch-clamp recordings of NMDA receptor-evoked postsynaptic currents (PSCs). 
A) The recordings were effectuated in stratum pyramidale (SP) of CA1 pyramidal cells in rat 
hippocampal slices. B) This picture shows the disposition of the recording (left) and the stimulation 
(right) electrodes. Note that the recording electrode is deeper into the slice than the stimulation one. C) 
Patching a CA1 pyramidal neuron. D) NMDA receptor-evoked postsynaptic currents being elicited by 
intervaled puff stimulation of NMDA (150µM). Calibration: A – 300µm; B – 120µm; C – 10µm D – 
400ms, 100pA. Photos A, B, C were adapted from Rombo, 2009.  
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Data acquisition was under the control of pCLAMP 10 Electrophysiology 
Data Acquisition and Analysis Software program (Axon Instruments Cellular 
Neurosciences product line of Molecular Devices Corp.). Data analysis was executed 
with Clampfit 10 (included in pCLAMP 10). Graph processing and statistic analysis 
were performed in Prism Version 6.00 for Mac OS X (GraphPad Software). 
 
4.3 – Pharmacological tools 
  
NMDA (N-methyl-D-aspartic acid) was obtained from Ascent Scientific Ltd 
(Bristol, UK); CGS 21680 (2-[4-(2-p-carboxyethyl)phenylamino]-5’N-
ethylcarbozamidoadenosine) that is a selective A2A receptor agonist and SCH 58261 
(7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5 
c]pyrimidine) that works as a selective A2A receptor antagonist, were obtained from 
Sigma-Aldrich (MO,USA). TTX (tetrodoxina citrate; Sodium-channel blocker), 
CNQX (6-cyano-7-nitroquinoxaline-2,3-dione), that acts as an antagonist of 
competitive AMPA/kainate glutamate receptors, was obtained from Tocris Bioscience 
(Bristol, UK) and DL-APV (2-amino-5-phosphonovaleric acid), that is a selective 
NMDA receptor antagonist, was obtained from Ascent Scientific Ltd (Bristol, UK). 
Isoflurane was obtained from Abbot Laboraties (Barcelona, Spain) and 1,2-
Propylenglycol from Merck (NJ, USA). CGS 21680 (5mM) and CNQX (100 mM) 
were prepared as a stock solution in dimethylsulfoxide (DMSO). TTX (1mM) was 
prepared in water as well as NMDA (100 µM) and DL-APV (50 mM). Stock 
solutions were aliquoted and stored at -20°C until use. Dilutions of these stock 
solutions to the final concentration were made freshly before each experiment. 
 
4.4 – Data analysis  
 
Values refer to mean peak amplitude of NMDA-evoked macroscopic currents 
and are represented as mean ± Standard Error of the Mean (SEM) from n 
experiments. Statistical significance was assessed by a two-tailed Student’s t test for 
the experimental versus control condition. A p value of 0.05 or less was considered to 
account for significant differences. Statistical analyses were conducted with the Prism 
Version 6.00 for Mac OS X (GraphPad Software). 
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RESULTS 
5 
 
Although there is a great deal of research involving A2A actions on 
hippocampal synaptic transmission, the modulatory roles of A2A receptors are still 
elusive. In hippocampal CA1 pyramidal neurons there are evidences that A2A 
receptors modulate the activity of AMPA receptors (Dias et al. 2012), but it is unclear 
if these receptors are able to modulate the activity of NMDA receptors in this 
hippocampal population.  
 
5.1 - Activation of adenosine A2A receptors facilitates NMDA receptor-evoked 
postsynaptic currents in CA1 pyramidal neurons 
 
In the first set of experiments the initial step was to achieve a steady and stable 
baseline of NMDA-evoked PSCs amplitudes. For that, NMDARs-mediated currents 
were evoked through pressure application (puff stimulation) of NMDA (150µM) 
(specific NMDAR agonist) directly onto the cell soma of the selected pyramidal 
neuron. The interval between each pressure application of NMDA was of two minutes 
and the baseline was always obtained after, at least, 5 consecutive puffs (10 minutes). 
When a stable baseline of NMDA-evoked PSCs was successfully obtained, the 
selective A2A receptor agonist CGS 21680 (30nM) was applied to the bath solution 
during 25 puffs (50 minutes). The CGS 21680 stock solution was prepared at a 
concentration known to be selective for adenosine A2A receptors, namely 30nM 
(Jarvis et al., 1989). It is also known that at this specific concentration CGS 21680 
activates A2A receptors in hippocampal slices (Sebastião & Ribeiro, 1992). 
Additionally, it is known that CGS 21680 has excitatory effects on hippocampal 
pyramidal cells (Li & Henry, 1998) and that it enhances AMPA-evoked currents in 
CA1 pyramidal neurons (Dias et al. 2012). As shown in figure 5.1.1, CGS 21680 
(30nM) enhanced NMDA-evoked currents in CA1 pyramidal cells. As can also be 
concluded from the time course of CGS 21680 (figure 5.1.2), the facilitatory effect 
started to be observed at about 5-10 minutes and the full effect occurred about 40 
minutes after CGS 21680 addition. Even during the perfusion of CGS 21680, it was 
evident that the PSCs started to decrease probably due to A2A receptor 
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desensibilization. Thus, at 30-40 min after GCS 21680 application (dark pink area in 
figure 5.1.2), the NMDA-evoked PSCs amplitudes were 135&±8.8% of baseline, 
whereas in the last ten minutes before washout, the PSC amplitude was 123±4.7% of 
baseline. Both values are statistically different from the control (before CGS 21680).  
 
Figure 5.1.1 – Illustrative current recordings of a representative experiment. The numbers in the 
currents represent the phases of the experiments identified in figure 5.1.2, panel A. The arrows 
identify the moment of brief (10 ms) applications of NMDA (150µM) into the cell soma. 1) PSC 
evoked 10 minutes before the application of CGS 21680; 2) PSC evoked during the last 10 minutes of 
CGS 21680 superfusion; 3) PSC evoked 20 minutes after the withdrawn of CGS 21 680 – washout 
phase. The NMDA-evoked PSC return to values close to the ones measured in the baseline phase.    
	   
 
 
 
Figure 5.1.2 – Adenosine A2A receptor agonist CGS 21680 modulates NMDA evoked-PSCs in 
CA1 pyramidal neurons. A) Time course plot of measured currents obtained from 6 experiments 
displaying that, during the time indicated by the horizontal bar (50 minutes illustrate in the area 
highlighted in light grey), selective A2A receptor agonist CGS 21680 (30nM) affects NMDA evoked-
PSCs recorded from CA1 pyramidal cells (Vh=-60mV). NMDA-evoked PSCs were evoked and 
measure with two-minute intervals. For statistical analyses, the PSCs were normalized to the 10 
minutes before CGS 21680 (30nM) application (100% = 480,1±63,9 pA). Significant statistical 
differences were found between current amplitude before and 50 minutes after CGS 21680 (30nM) 
application: 123%±4,7% of baseline, n=6, p<0.005, paired Student’s t test. B) The full effect occurred 
about 40 minutes after the application of CGS 21680 (dark grey area in panel A). In this period the 
NMDA-evoked PSCs increased to 135%±8.8% of baseline n=6, p<0.05. 
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Figure 5.1.3 – CGS 21860 withdrawn significantly altered NMDA-evoked mean peak PSCs 
amplitudes. B) PSCs mean peak amplitude during the washout procedure decreased significantly, 
when compared with the last 10 minutes of CGS 21 680 application. Upon CGS 21680 washout, there 
was a 20,0%±12,0% decrease in average NMDA-evoked PSCs amplitude to 105%±2.5% of baseline 
values. There are no significant statistical differences when comparing the mean differences between 
the baseline period and the washout period: 105%±2.5% of baseline, n=4 p>0,05 (100% = 483,3 ± 93,3 
pA). 
 
The effect of CGS 21680 (30nM) was fully reversible upon washout. As it is 
shown in figures 5.1.3, in the experiments in which it was possible to withdrawn the 
agonist from the solution in a washout procedure, NMDA-evoked PSCs peak 
amplitudes decreased significantly, when compared with the last 10 minutes of CGS 
21 680 application. In the time course plot displayed in figure 5.1.2, it can be 
observed that NMDA-evoked PSCs in the last 10 minutes of the washout procedure 
decreased to values really close to the baseline: 105%±2.5% of baseline, n=4 p>0,05. 
Upon CGS 21680 washout, there was a 20%±12% decrease in average NMDA-
evoked PSCs amplitude.   
The results of this first set of experiments strongly suggest that adenosine A2A 
receptors are responsible for a modulation of NMDA-evoked PSCs in CA1 pyramidal 
cells, this modulation being a potentiation of NMDA-evoked PSCs.   
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5.2 – Endogenous A2A receptors does not contribute for the measured NMDA-
evoked PSCs 
 
 To better characterize and describe the effect of the A2A agonist upon NMDA-
evoked PSCs, it was considered important to understand if the endogenous adenosine 
present in the cell environment contributes for the increase in the PSCs. The use of 
the selective A2A antagonist SCH 58261 (100nM) blocks the possible action of 
endogenous adenosine and allows comparing a period of baseline without the 
presence of any drug with a period where the antagonist is present.  
 
Figure 5.2.1 – Illustrative current recordings. The numbers in the currents represent the two 
different periods of the experiments identified in the time course displayed in figure 5.2.2. The arrows 
are signalling the moment of brief (10 ms) applications of NMDA (150µM) into the cell soma. 1) PSC 
evoked 10 minutes before the application of SCH 58261 (100nM); 2) PSC evoked during the last 10 
minutes of SCH 58261 (100nM) superfusion.  
 
Figures 5.2.1 and 5.2.2 show that there were no significant differences 
between the NMDA-evoked PSCs measured before and after the superfusion of A2A 
receptor antagonist SCH 58261 (100nM). The statistic analysis showed that there 
were no statistically significant differences between both periods, with average 
NMDA-evoked amplitude currents being 103%±14,5% of baseline, n=3, p>0.05. 
These data suggest that, with the recording conditions used in these experiments, 
endogenous adenosine does not regulate NMDA receptor responses 
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Figure 5.2.2 - Endogenous A2A receptor activity does not contribute for the measured NMDA-
evoked PSCs. Time course plot of measured currents obtained from 3 experiments displaying that, 
during the time indicated by the horizontal bar (30 minutes, green area), the selective A2A receptor 
antagonist SCH 58261 (100nM) does not affect NMDA evoked-PSCs recorded from CA1 pyramidal 
cells (Vh=-60mV). NMDA-evoked PSCs were evoked with two-minute intervals. For statistical 
analyses, the PSCs were normalized to the 10 minutes before SCH 58261 (100nM) application (100% 
= 243,6±47.0 pA). No significant statistical differences were found between current amplitude peaks 
before and 30 minutes after SCH 58261 (100nM) application: 102,8%±14,5% of baseline, n=3, p>0.05, 
under Student’s t test.  
 
5.3 - Previous application of adenosine A2A receptors antagonist blocks the effect 
of adenosine A2A receptors agonist 
 
A classic pharmacological control was designed to assure that the increase 
registered in NMDA-evoked PSCs after the administration of CGS 21680 was due to 
A2A receptor activity. For that, the selective adenosine A2A receptor antagonist SCH 
58261 (100nM) was superfused in the bath solution before (at least 10 minutes) the 
addition of A2A receptor agonist CGS 21680 (30nM). The reason behind this protocol 
was that any effect mediated by A2A receptors would be prevented by the presence of 
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the antagonist since previous application of the antagonist at superior concentrations 
would occupy the A2A receptors, preventing the binding of the A2A receptor agonist.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.1 - Previous application of adenosine A2A receptors antagonist blocks the effect of 
adenosine A2A receptors agonist. Time course plot of measured currents obtained from 5 experiments 
displaying that, during the time indicated by the horizontal bar located at the top of the graph (30 
minutes, blue area) and in the presence of selective A2A receptor antagonist SCH 58261(100nM), the 
selective A2A receptor agonist CGS 21680 (30nM) does not affect NMDA evoked-PSCs recorded from 
CA1 pyramidal cells (Vh=-60mV). NMDA-evoked PSCs were evoked with two-minute intervals. For 
statistical analyses, the PSCs were normalized to the 10 minutes before CGS 21680 (30nM) application 
(100% = 336.9±133.0 pA). No statistical significant differences were found between current amplitude 
peaks before and 30 minutes after CGS 21680 (30nM) application: 102,2%±9,0% of baseline, n=5, 
p>0.05, under Student’s t test.  
 
As illustrated in the time course displayed in figure 5.3.1 and in data 
represented in figure 5.3.2, in the presence of the selective A2A receptor antagonist the 
A2A receptor agonist was clearly devoid of effect upon NMDA-evoked PSCs 
(102,2%±9,0% of baseline, n=5, p>0.05).  
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Figure 5.3.2 – SCH 58261 and CGS 21680 simultaneous application did not altered the mean 
peak amplitude of NMDA-evoked PSCS. Mean effect of selective A2A receptor agonist CGS 21680 
(30nM) superfusion in the presence of previously administrated selective A2A receptor antagonist SCH 
58261 (100nM) on peak amplitude of NMDA-evoked PSCs from CA1 pyramidal cells. PSCs peak 
amplitude during the last 10 minutes of the CGS 21680 (30nM) application in the presence of SCH 
58261 do not significantly differ when compared with the last 10 minutes of SCH 58261 (100nM) 
individual application: 102,2%±9,0% of baseline, n=5, p>0.05, paired Student’s t test.  
 
5.4 - Application of AMPA/kainate antagonist does not alter the evoked PSCs 
 
 Until now the pharmacological controls made to further describe and 
characterize the nature of the A2A receptor agonist CGS 21680 modulatory effect 
upon postsynaptic currents evoked by NMDA receptor activity were focused only in 
the adenosinergic component of the effect. We next addressed if the NMDA-evoked 
PSCs being measured mainly reflect NMDA receptor activity. Therefore, specific 
drugs to block the activity of other ionotropic glutamate receptors (AMPA and 
kainate receptors) were used. A selective competitive antagonist for AMPA and 
kainate receptors, CNQX (10µM) was chosen to selectively block the activity of these 
receptors.  
 As it is possible to observe in figure 5.4.1 the administration of a competitive 
AMPA/kainate antagonist did not significantly alter the mean peak amplitudes of 
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NMDA-evoked PSCs (99.0%±2.9% of baseline, n=3, p>0.05). These data suggest 
that these glutamate receptors did not significantly contribute for the postsynaptic 
currents that were being measured.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.1 – AMPA/kainate competitive antagonist CNQX did not altered the mean peak 
amplitude of NMDA-evoked PSCs. Effect of AMPA/kainate receptor antagonist CNQX (10µM) on 
mean peak amplitude of NMDA-evoked PSCs from CA1 pyramidal cells. Mean peak PSCs amplitudes 
during the last 10 minutes of CNQX (10µM) application do not significantly differ, comparing with the 
baseline: 99.5%±3.3% of baseline, n=3, ns. p>0.05, paired Student’s t test (100% = 132,7±11,6 pA). 
   
5.5 - Application of selective NMDA receptor antagonist cancels the evoked PSCs 
 
 After observing that AMPA and kainate glutamate receptors are not 
accountable for the currents that were measured, one more step was taken to make 
sure that only NMDA receptors contributed for the elicited postsynaptic currents. DL-
APV (50µM) is a selective NMDA antagonist that competitively inhibits glutamate 
binding to the allosteric site of NMDA receptors. A substantial decrease, if not 
abolishment, of the PSCs being measured was expected if in fact these currents were 
being mediated by NMDA receptors.  
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Figure 5.5.1 – NMDA receptor selective antagonist significantly reduces peak amplitudes of 
NMDA evoked-PSCs. Effect of NMDA receptor antagonist DL-APV (50µM) on peak amplitude of 
NMDA-evoked PSCs from CA1 pyramidal cells. The absolute value on peak amplitude of NMDA-
evoked PSCs during the last 10 minutes of the DL-APV (50µM) application significantly decreased 
when compared to both baseline period and CNQX administration: 23.9±4.9 pA, n=3, p<0.005, paired 
Student’s t test. 
 
   
 
 
 
 
 
 
 
 
 
 
Figure 5.5.2 – NMDA receptor selective antagonist significantly reduces mean peak amplitudes of 
NMDA evoked-PSCs. Effect of NMDA receptor antagonist DL-APV (50µM) on mean peak amplitude 
of NMDA-evoked PSCs from CA1 pyramidal cells. Mean peak amplitude of NMDA-evoked PSCs 
during the last 10 minutes of the DL-APV (50µM) application significantly decreased when compared 
to the baseline period: 23.9±4.9 of baseline, n=3, p<0.005, under Student’s t test (100% = 132,7±11,6 
pA). 
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The graph displayed in figure 5.5.1 shows that the administration of DL-APV 
(50µM) caused a significant decrease in NMDA-evoked PSCs, when compared with a 
baseline period in which there was no NMDA antagonist present. Although there was 
a marked decrease in the measured postsynaptic currents, it is curious that those 
currents were not completely abolished. 
 
DISCUSSION 
6 
 
The main findings in the present work were that A2A adenosine receptors 
facilitate NMDA receptor activity in CA1 hippocampal pyramidal neurons. The 
results obtained in this investigation clearly suggest that the administration of the 
selective adenosine A2A receptor CGS 21680 facilitated the excitatory responses 
mediated by NMDA receptor activity. This is a not yet described modulatory effect of 
adenosine A2A receptors upon NMDA receptor activity in CA1 neuronal population. 
Given the ambivalent roles played by NMDA receptors in neuronal cell death 
processes, synaptic plasticity phenomena and correct development of the synapses, a 
full understanding of NMDA receptor activity regulation is extremely important.  
 
6.1 - Modulatory effect of adenosine A2A receptor upon NMDA-evoked 
postsynaptic currents 
 
Adenosine is a neuromodulator known to influence the action of ionotropic 
glutamate receptors such as NMDA receptors (Sebastião & Ribeiro, 2000). Data 
obtained in recent investigations about the modulatory actions of A2A receptors upon 
NMDA receptor activity it is still very scarce, even contradictory. In contrast to the 
well-known inhibitory ability of A1 receptors to control excitatory synaptic 
transmission, adenosine A2A receptors facilitate synaptic transmission (Cunha et al. 
2008).  
When compared with a baseline period free of agonist administration, the peak 
amplitude of NMDA-evoked PSCs markedly increased when A2A receptors were 
activated with CGS 21680. The fact that upon washout of the agonist the peak 
amplitude of the currents significantly decreased, supports the conclusion that this 
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effect was indeed caused by the action of the selective A2A receptors agonist CGS 
21680. Furthermore, when the selective A2A receptor antagonist SCH 58261 was 
administrated previously to CGS 21680, the facilitatory effect mediated by the agonist 
upon the registered NMDA-evoked currents was abolished. This indicates that the 
previous administration of a competitive antagonist resulted in the binding of the 
antagonist to the receptor allosteric sites of the A2A receptors occupying the available 
binding sites. Ultimately this resulted in the dampening of the agonist-mediated 
response that was previously induced by CGS 21680 administration. 
 
6.2 – A presynaptic facilitation in the release of glutamate or a postsynaptic 
modulatory interaction between receptors? 
 
Given that the actions of CGS 21680 in pyramidal cells are linked with 
excitatory effects mediated by A2A receptors located both at presynaptic and 
postsynaptic locations (Li & Henry, 1998), it seems needed to debate if this is a reflex 
of a presynaptic increase in neurotransmitter release, induced by the A2A agonist CGS 
21680 presynaptic facilitatory action upon glutamate release (Lopes et al. 1999) or, 
on the other hand, reflects a postsynaptic interaction between NMDA receptors and 
A2A receptors located at the postsynaptic cell.  
It is rather unlikely that the results reported in this work occur due to a 
presynaptic facilitation in glutamate release. First of all, the use of Tetrodotoxin, 
commonly known as TTX, allowed the blockade of action potential generation and all 
the spontaneous neuronal activity. By binding to the fast sodium voltage-gated 
channels located in the membrane of the nerve cells, TTX essentially prevents the 
firing of any affected nerve cell by blocking the channels used in the process. By 
using TTX in these experiments it was guaranteed that the presynaptic release of 
neurotransmitter was hindered, since neurotransmitter release is triggered by the 
arrival of an action potential. TTX blocks the possibility of having action potentials 
and therefore it is impossible for the presynaptic cell to produce the necessary calcium 
influx of calcium ions through voltage-dependent calcium selective ion channels. It 
would be these calcium ions that would bind to the proteins of the synaptic vesicle, 
allowing the vesicles to fuse with the presynaptic cell membrane and to release the 
neurotransmitter. Even with the presence of CGS 21680 in all the surrounding 
environment of the pyramidal cell under study by its superfusion in the bath solution, 
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it would impossible for the agonist to augment the release of neurotransmitter and 
hence increase NMDA receptor activity exclusively through presynaptic glutamate 
release facilitation.  
The experimental protocol was designed to minimize the possibilities of 
presynaptic influences. Indeed, currents were being evoked through pressure 
application of NMDA, therefore bypassing activity dependent neurotransmitter 
release. Together with the use of TTX it becomes highly unlikely that NMDA 
receptor increased their activity due to an exacerbation in presynaptic glutamate 
release.   
It seems likely that the facilitatory effect induced by the selective adenosine 
A2A agonist upon NMDA-evoked PSCs in CA1 pyramidal neurons occurred due to a 
postsynaptic interaction between NMDA and A2A receptors. Being so, these results 
must be interpreted together with other postsynaptic cross talks between modulatory 
adenosine receptors and NMDA glutamate receptors. 
 
6.3 – Postsynaptic interaction between adenosine A2A receptors and NMDA 
receptors  
 
 The postsynaptic interactions between adenosine A2A receptors and NMDA 
receptors discovered until now differ accordingly to the hippocampal area in which 
they are described. Besides that, these interactions are not always straightforward, in 
the sense that they can be contradictory to what is expected. Clearly this subject needs 
more research to fully comprehend the mechanism that underlie the modulatory 
actions of A2A receptors upon NMDA receptor mediated currents and the 
consequences of this particular neuromodulatory interaction.   
In the striatum, it is known that the activation of A2A receptors through agonist 
administration leads to an inhibition in the conductance of NMDA receptor channels. 
However, this only appears to happen in Mg2+ free environments, meaning in 
situations where NMDA receptors are not blocked by the presence of extracellular 
Mg2+. In fact, when NMDA receptors are blocked, the predominant modulatory action 
of adenosine A2A receptors is to presynaptically inhibit the release of GABA (Wirkner 
et al. 2004). It is important to refer that in the set of experiments now reported, Mg2+ 
was also withdrawn from the bath solution in all the experiments, since extracellular 
Mg2+ is known to inhibit NMDA receptor at resting membrane potentials. However, 
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in contrast of what occurs in the striatum, the A2A receptor agonist significantly 
augmented the currents mediated by NMDA receptors in CA1 pyramidal neurons. If 
the facilitation mediated by A2A receptors upon NMDA-evoked postsynaptic currents 
when there is no Mg2+ present in the cellular environment constitutes a mechanism 
exacerbating the possible deleterious actions of NMDA receptor activity concerning 
excitotoxic insults at the hippocampus is still elusive. Alternatively, facilitation of 
NMDA receptor activation may facilitate synaptic plasticity processes at the CA1 
hippocampal area. Regardless, it is really intriguing that in situations favourable to 
NMDA receptor activity (no Mg2+ present to block their activity) A2A receptors seem 
to display a further facilitatory effect over activation of NMDA receptors.  
As I show here, A2A receptor selective agonist administration resulted in the 
increase of NMDA-evoked PSCs. Adjunctively with the circumstance that there was 
no Mg2+ in the cellular environment and that the co-agonist was also present, 
ultimately this could mean that the modulatory facilitation effect of A2A upon NMDA 
receptor activity would result in deleterious consequences for the cell, due to NMDA 
receptor over activation. However, the localization of the NMDA receptors being 
stimulated is crucially important to determine if NMDA receptor activation results in 
excitotoxic insults or synaptic plasticity. As referred in the introduction, more than the 
amount of calcium ions per se that flows through NMDA receptors, the influx of 
calcium ions into the postsynaptic cell through NMDA receptor located 
extrasynaptically is the most important factor determining the consequences of this 
increase in NMDA receptor activity (Hardingham et al. 2002). The influx of Ca2+ 
through synaptic NMDA receptors is well tolerated by the neuronal hippocampal 
cells. Additionally, it is associated with mechanisms that activate genomic processes 
that can make neuronal cells more resistant to apoptosis and oxidative processes 
(Hardingham et al. 2002).  
There is also the question if this increase in NMDA receptor activity induced 
by A2A receptor agonist administration could contribute to forms of LTP dependent 
on NMDA receptor activity in CA1 pyramidal neurons. In fact, CA1/CA3 LTP forms 
are mainly dependent on NMDA receptor activity (Sebastião & Ribeiro, 2009). 
However, some investigations have found that at CA1 hippocampal region, adenosine 
A2A receptors activation is responsible for the induction of a LTP form that is 
independent of NMDA receptors (Kessey & Mogul, 1997). Curiously, knowing that 
at the mossy fibers/CA3 LTP forms are mainly independent on NMDA receptor 
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functioning (Sebastião & Ribeiro, 2009), some results show that, in the synapses 
localized between CA3 regions and mossy fibers synapses, the activation of A2A 
receptors through agonist administration is related with the induction of a form of 
LTP mediated by postsynaptic NMDA receptors that spares AMPA currents. This 
form of LTP requires a simultaneous activation of NMDA receptors, mGluR5 
receptors as well as A2A receptors that ultimately lead to intracellular elevations in 
Ca2+ concentrations inside the postsynaptic neurons, triggering the LTP (Rebola et al. 
2008).  These two forms of LTP later described are somehow contradictory to what is 
characteristic in those hippocampal areas. It therefore appears that A2A receptors are 
linked with secondary forms of plasticity in the hippocampus (Sebastião & Ribeiro, 
2009). To understand if the increase in NMDA receptor activity mediated by 
adenosine A2A receptors activation could lead to NMDA-dependent forms of LTP in 
CA1 pyramidal areas would constitute an important step to the work now reported. 
 
6.4 – Contribution of extrasynaptic vs. synaptic NMDA receptor population for 
the observed effect  
 
Glutamate excitotoxicity is identified as a key component in many 
neurodegenerative and neurologic diseases (Xu et al. 2009). NMDA receptors are the 
main responsible agents for the excessive and neurotoxic increase of Ca2+ inside the 
neuronal cell. In situations in which the postsynaptic cell is exposed to high levels of 
glutamate, it can lead to an over activation of NMDA receptors. Ultimately, It would 
lead to a significant increase in Ca2+ concentration inside the postsynaptic neuron (Xu 
et al. 2009). Ion calcium entrance through NMDA receptors is especially efficient in 
causing neuronal cell death, when compared to its entrance through other ionic 
channels (Hardingham & Bading, 2010). On the other hand, NMDA receptor activity 
can also be linked to molecular pathways favouring neuronal survival and synaptic 
plasticity processes (Xu et al. 2009).  
Given the characteristics of the procedure designed for this investigation, it 
seems more likely that the NMDA-evoked PSCs were being mediated mainly by 
extrasynaptic NMDA receptors. First of all, it is important to remind that, in the 
young-adult brain, three-quarters of the NMDA receptors are extrasynaptically 
located in immature hippocampal neurons (Hardingham & Bading, 2010). Although 
there is an increase in synaptic located NMDA receptors throughout brain 
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development, in the adult brain the major part of these receptors are still 
extrasynaptically located (Hardingham & Bading, 2010). The pressure stimulation 
procedure used to directly stimulate the activity of NMDA receptors (puff stimulation 
with NMDA) creates a condition in which the agonist is applied to the entire 
surrounding cellular environment and not to specific regions or populations (in fact, 
the stimulation electrode is often placed above the registered neuron in order to assure 
that the puff affects all the cell). This way, and knowing that in the adult rat brain 
there higher amount of extrasynaptic NMDA receptors compared to synaptic ones, it 
seems highly probable that the NMDA-evoked PSCs were mainly mediated by 
extrasynaptic NMDA receptors. However, it would be necessary to create another 
experimental condition to fully understand this point.   
There are two main ways of achieving this goal in electrophysiological 
procedures. Through afferent stimulation it could be possible to stimulate only the 
synaptically located NMDA receptors, therefore studying their contribution to the 
modulatory effect caused by A2A agonist application. By changing the protocol used 
in this investigation, it could be possible to electrically stimulate the afferent nerves of 
the selected pyramidal neuron. The electrical stimulation of the afferent nerves of the 
presynaptic neuron would result in an increase in transmitter release. Glutamate is the 
main excitatory neurotransmitter and increases in glutamate release due to the 
electrical stimulation of the presynaptic neuron could activate the NMDA receptors 
located only in the postsynaptic cell and not the extrasynaptic NMDA receptor 
population. Measuring the NMDA-evoked PSCs in synaptic NMDA receptors 
population (under AMPA/kainate receptor blockade with a selective antagonist) and 
subsequently adding adenosine A2A receptor agonist CGS 21680, would allow 
understanding if the modulatory effect still occurs when only synaptic NMDA 
population is being activated and if the effect is smaller than the one being registered. 
Although this experimental design could exclude some of the difficulties created by 
pressure stimulation procedures, it has serious limitations that are difficult to control. 
For instance, if the electrical stimulation of the presynaptic neuron was not perfectly 
adjusted, it could result in a spill over of glutamate. The excessive concentration of 
glutamate could migrate to the extrasynaptic areas of the postsynaptic neuron and 
therefore activate extrasynaptically located NMDA receptors.  
Another way to selectively control the activity of a specific NMDA receptor 
population is to use memantine, a drug that preferentially blocks extrasynaptic over 
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synaptic NMDA receptor currents in the hippocampus (Xia et al. 2010). At 
micromolar concentrations (1-10 µM), memantine has the particularity of 
preferentially block extrasynaptic NMDA receptor activity rather than synaptic 
NMDA receptor currents in the same neuron (Xia et al. 2010). This tool is of 
particular interest to achieve the subsequent goals in this investigation. Memantine 
superfusion in the bath solution would allow the maintenance of all the procedure 
apparatus. NMDA receptor activity could continue to be evoked through pressure 
stimulation with direct agonist NMDA. This way, the modulatory effects of A2A 
receptor agonist CGS 21680 upon NMDA-evoked PSCs could be attained in a 
condition were memantine was superfused in the bath solution and in a memantine-
free condition, which would be used as a control condition. This would allow 
understanding the relative contribution of extrasynaptic NMDA receptor population to 
the modulatory effect caused by adenosine A2A receptor agonist. In the eventuality 
that memantine causes a significant decrease in NMDA-evoked PSCs, one could 
argue that the effect occurred due to an interaction between A2A receptors and 
extrasynaptic NMDA receptors (as predicted in this investigation). This could mean 
that the modulatory A2A receptor effect upon NMDA receptor activity uncovered in 
this work could ultimately result in deleterious consequences for the neurons.  
 
6.5 – The role of adenosine A2A receptors and metabotropic glutamate receptors 
5 (mGluR5) in NMDA-dependent forms of LTP in CA1 hippocampal areas 
 
It is already describe that adenosine A2A receptors are essential for a form of 
LTP that is dependent of NMDA-evoked excitatory postsynaptic currents at synapses 
located between the mossy fibers and CA3 pyramidal cells. This form of LTP does 
not demand the contribution of AMPA generated postsynaptic currents and it is likely 
induced and expressed at a postsynaptic level. It requires an elevation in Ca2+ 
concentration inside the postsynaptic cell and, for that, it is essential a co-activation of 
NMDA receptors and mGluR5 receptors. In addition, it is also necessary to activate 
adenosine A2A receptors, which means that this is not a tonic effect, requiring synaptic 
stimulation (Rebola et al. 2008). The co-activation of NMDA receptors and mGluR5 
receptors is a particular efficient way of increasing the concentration of Ca2+ inside 
the postsynaptic cell, having into account that the increase in Ca2+ concentration is the 
triggering element for LTP of NMDA-EPSCs, it seems that A2A receptors, NMDA 
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receptors and mGluR5 receptors act synergistically to promote the durable 
potentiation of NMDA-EPSCs (Rebola et al. 2008). Accordingly, it is know that the 
co-activation of A2A and mGluR5 receptors positively modulates NMDA receptor 
function (Tebano et al. 2005). In fact, the pharmacological activation of both NMDA 
and mGluR5 receptors potentiates NMDA-EPSCs inducing a long-lasting enhancing 
of excitatory synaptic transmission (Kotecha et al. 2003). This way, it looks like that 
these three types of receptor are necessary for the induction of NMDA-ESPCs LTP.  
Interestingly, it is known that the activation of metabotropic receptors with 
selective agonists potentiates cAMP responses mediated by receptors that are 
positively coupled to adenylyl cyclase, such as A2A receptors (Alexander et al. 1992). 
It seems that adenosine A2A receptors and mGluR5 receptors are intimately connected 
and that their synergetic action modulates several processes. It would be interesting to 
investigate if the mGluR5 play some kind of role in experimental conditions in which 
adenosine A2A receptors are modulating the activity of NMDA-evoked PSCs. As it 
was mentioned before, understanding if a simultaneous activation of A2A, mGluR5 
and NMDA receptors could be responsible for a form of LTP dependent on NMDA-
EPSCs in CA1 pyramidal cells would be extremely interesting and could expose an 
effect not yet described.   
 
6.6 – DL-APV did not cancel NMDA-evoked PSCs completely 
 
Somehow unexpected was the lack of ability of DL-APV to completely cancel 
NMDA-evoked postsynaptic currents. DL-APV is a selective NMDA antagonist that 
competitively inhibits glutamate binding to the allosteric site of NMDA receptors. 
The utilization of this drug functioned as an important control to assure that the 
measure postsynaptic currents were exclusively mediated by NMDA receptors. Being 
a competitive, selective and efficient NMDA receptor antagonist, it was expected that 
the amplitudes of PSCs would be fully blocked by APV. Furthermore, taking into 
account that DL-APV was superfused in the presence of competitive AMPA/kainate 
receptors antagonist CNQX, by adding DL-APV every source capable of emitting 
PSCs in response to a pressure stimulation of NMDA or the presence of glutamate 
was blocked with an antagonist. Therefore, the expected result was to see the PSCs 
decrease to levels really close to zero or even to be completely cancelled.  
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There were some time limitations in this project that did not allow the increase 
in number of experiments using this APV. It would be relevant to increase the number 
of experiments, replicating all the procedure and ascertain if the NMDA-evoked PSCs 
are completely cancelled in the new experiment. Indeed, in in two of the three 
experiments considered, NMDA receptor-evoked currents were almost completely 
blocked and in the other one these currents reduced significantly. Being so, there are 
reasons to believe that this result could be replicated in further experiments. The 
concentration used in DL-APV should be increased. There are tow isoforms of the 
antagonist APV, the DL-APV (the one used in this investigation) and D-APV. The 
active isomer of APV is considered to be the D configuration but racemic chemical 
mixtures have created the mixture of D- and L- isomers, such as DL-APV, a racemic 
mixture between equal amounts of enantiomers of the chiral molecule. The chiral 
form DL-APV is relatively less active and specific than D-APV, and normally is used 
in smaller concentrations to fully block NMDA receptor activity. It may have happen 
that the concentration used in the preparation of DL-APV solution was not enough 
(50µM) when considering the experiment conditions.  It is important to remind that 
the activity of NMDA receptors was stimulated through direct application of NMDA 
in a significant concentration (150µM). Also, the presence of glycine in both bath 
solution and rest solution, adjunctively with the extracellular Mg2+ withdrawn from 
the bath solution, were used to increase the probability of NMDA receptor activity 
making it more difficult for DL-APV to block NMDA receptor activity. Given that 
the pressure system is sending NMDA directly to the cell soma, this direct agonist 
will actively compete with the antagonist for the allosteric sites in the NMDA 
receptor. With the procedure configuration, probably it would have been more 
adequate to double the DL-APV concentration to 100 µM.  
Nevertheless, in two of the three experiments considered, the reduction in 
NMDA-evoked PSCs was notorious, displaying current values close to zero. CNQX 
and TTX application in these experiments is really important because it allowed to 
discard the contribution of other glutamate receptors for the measured currents as well 
as a possible presynaptic facilitation in glutamate release that could augment the 
activity of these receptors. Moreover, previous experiments conducted at the host lab 
discard the possibility of the setup having some interference in the evoked currents. 
The puff stimulation electrode could in fact create some friction in the recording cell 
and therefore be responsible for the evoking of any current. However, this was 
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previously controlled did not occur. This way, it can be discarded a possible physical 
damaged caused by the electrode upon the recording neuron.  
Summarizing, in future experiments it is necessary to replicate the 
experiments using a higher concentration of DL-APV to observe if with the new 
concentration the currents mediated by NMDA receptor activity are completely 
cancelled.           
 
GENERAL CONCLUSIONS 
7 
  
The present results provide in first hand direct evidence that in CA1 pyramidal 
neurons the selective adenosine A2A receptor agonist CGS 21680 is responsible for a 
modulatory effect that potentiates NMDA receptor activity, increasing the 
postsynaptic currents mediated by these receptors. This effect seems to be exclusively 
mediated by the action of A2A receptors upon NMDA receptors.  
 Further studies are necessary to discriminate between the relative sensibility of 
synaptic and extrasynaptic NMDA receptor population to the effect of A2A receptor 
agonist.  This could allow foreseeing the functional consequences of the A2A receptor 
mediated modulation, given the different role of synaptic and extrasynaptic NMDA 
receptors for neuronal functions. 
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